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Chapter 1
General introduction




During pregnancy, maternal physiological changes and fetal demands for growth 
and development increase the requirements of micronutrients [1]. Micronutrient 
deficiency, which is a common problem in both developing and developed countries 
[2, 3], is found to be associated with adverse neonatal and pregnancy outcomes [2, 
4, 5]. Anemia can occur if there is a deficiency in iron, folic acid, or vitamin B12, since 
these micronutrients are needed for adequate production of red blood cells [6]. 
Anemia can result in  a reduced perceived health status (HS) or quality of life (QOL) 
[7, 8], and increased fatigue [9]. Also, vitamin D deficiency is reported to be related to 
HS [10] and fatigue [11, 12]. The current literature on postpartum micronutrient status 
focuses on lactating women and the impact of the amount of micronutrients secretion 
in breast milk on infant development [13]. So far, only little attention has been paid to 
the consequences of micronutrient depletion on maternal HS and fatigue during the 
postpartum period. Improved knowledge of postpartum micronutrient deficiencies 
and its association with maternal HS is important, in order to determine the need for 
supplementation. In this thesis, we examine anemia, iron, folic acid, vitamin B12, and 
vitamin D in association with HS and fatigue in postpartum women.
Postpartum health status and quality of life
Since health care is becoming more and more patient centered, patient-reported 
outcomes (PROs) become increasingly important. Frequently used aspects of PROs 
are QOL and perceived HS, which are multidimensional concepts that incorporate 
at least the physical, psychological, and social aspects of life [14]. These aspects are 
derived from the World Health Organization’s (WHO) definition of health that is “a 
state of complete physical, mental and social well-being and not merely the absence 
of disease or infirmity” [15]. QOL is defined by the WHOQOL group as “individuals’ 
perception of their position in life in the context of the culture and value systems in 
which they live and in relation to their goals, expectations, standards and concerns” 
[16]. The difference between HS and QOL is that where HS refers to self-perceived 
physical, psychological and social functioning, QOL also incorporates the patients’ 
evaluation of functioning with these aspects of life [14]. Both HS and QOL can be used 
to measure the perceived condition and to assess the effect of interventions [14]. Even 
though these terms are often used interchangeably, it is important to distinguish 
them from each other, as they may give different outcomes [17, 18]. In this thesis, we 
were interested in both QOL and HS in postpartum women (chapter 2). In addition, 




we examined the association of postpartum micronutrient status and maternal HS 
and fatigue.
Postpartum micronutrient deficiency associated with health status and fatigue
Anemia can be caused by iron, folic acid or vitamin B12 deficiency [6]. In the current 
literature, anemia, whether or not caused by micronutrient deficiency, and vitamin D 
deficiency were found to be associated with impaired HS [7, 10] and increased fatigue 
[9, 11, 12]. Treatment of postpartum anemia is based on the assumption that fatigue 
will reduce and HS will improve, since fatigue is considered to be the major symptom 
of anemia [9]. An observational study of Jansen et al. found that the hemoglobin 
(Hb) level was correlated with physical HS and fatigue immediately postpartum, 
but disappeared one week postpartum [19]. As far as we know, there are no data 
comparing HS and fatigue among postpartum anemic and non-anemic women. 
In this thesis, we examined the difference in HS and fatigue between postpartum 
anemic and non-anemic women during the first five weeks postpartum (chapter 3).
Vitamin D deficiency was found to be associated with fatigue in the general population 
[11, 12] and with impaired HS in premenopausal women [10]. The prevalence of 
vitamin D deficiency and insufficiency during pregnancy ranges from 25 to 100%, 
depending on the country of residence [20]. At six to eight weeks postpartum, 
inadequate vitamin D levels were reported in 23% of Danish and 99.7% of Indian 
lactating women [21, 22]. Interestingly, the prevalence of vitamin D deficiency in 
bottle feeding postpartum women is unknown. Currently, international guidelines 
recommend supplementation of 10 – 15 micrograms (= 400 – 600 UI) vitamin D 
per day for pregnant and lactating women, in order to reduce the risk of vitamin D 
deficiency of the newborn [23, 24]. However, if vitamin D insufficiency in postpartum 
women is related to HS and fatigue, vitamin D supplementation might also be 
applied for all postpartum women independent of lactation. In this thesis, we studied 
the prevalence of vitamin D sufficiency and insufficiency in postpartum women, in 
relation to infant feeding method, HS and fatigue (chapter 4).
Postpartum anemia
Causes of postpartum anemia may include: hemodilution [8, 25], peripartum 
hemorrhage [25, 26], or deficiencies of micronutrients for erythropoiesis such as 
iron, folic acid [6, 25], and vitamin B12 deficiency. Only a minority of postpartum 
anemia is caused by vitamin B12 deficiency [25]. Nevertheless, low serum vitamin B12 
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levels are frequently found in postpartum women. It is known that serum vitamin 
B12 levels decrease during pregnancy, and recover spontaneously postpartum to 
preconceptional values [27, 28]. Despite the decrease of vitamin B12 to marginal or 
non-pregnant deficient values, there is no evidence of a true vitamin B12 deficiency. 
Homocysteine and methylmalonic acid levels, which are normally used to define 
vitamin B12 deficiency, were not significantly correlated with vitamin B12 deficiency 
both during pregnancy and postpartum [27, 28]. Therefore, the observed change is 
considered to be physiological and caused by a mechanism of redistribution of vitamin 
B12 bound to the proteins transcobalamin (holoTC) and haptocorrin (holoHC) [27, 
29]. HoloTC is the metabolic active part of vitamin B12 available for tissue uptake [30] 
and has shown to be a more sensitive marker of early vitamin B12 changes compared 
with serum vitamin B12 in the general population [31, 32]. In this thesis, we examined 
the prevalence of vitamin B12 deficiency based on serum vitamin B12 and holoTC 
within 48 hours and at five weeks postpartum (chapter 5). Our hypothesis is that a 
shift occurs towards holoTC in women with insufficient available total vitamin B12. 
Therefore, the fraction of active vitamin B12 (holoTC/total vitamin B12) was compared 
between postpartum women with and without vitamin B12 deficiency (chapter 5).
Iron deficiency, ultimately resulting in iron deficiency anemia, is the most common 
form of malnutrition in the world and is highly prevalent in both developing and 
developed countries [33]. Because it is believed that the major causes of postpartum 
anemia include pre-existing iron deficiency and iron deficiency anemia in combination 
with excessive blood loss during delivery [3, 34], international guidelines recommend 
iron supplementation for the treatment of postpartum anemia [25, 34-36]. However, 
treatment guidelines of postpartum anemia are currently based on Hb level, 
without distinction between the etiologies of anemia [25, 34-36]. Yet, low Hb levels 
postpartum could be due to hemodilution [8, 25] or postpartum hemorrhage [26, 34]. 
Basing the treatment of anemia on Hb level alone, could lead to overtreatment in 
routine iron supplementation. Therefore, it is important to diagnose iron deficiency 
in anemic postpartum women. Iron deficiency is usually diagnosed by determination 
of a decreased level of serum ferritin [37, 38]. However, in the early postpartum 
period, serum ferritin can be false normal or false high, because of its prominent role 
in the acute phase response during parturition [36, 39]. For this reason, in this thesis, 
reticulocyte hemoglobin content (CHr) and mean corpuscular volume (MCV) were 
used to identify iron deficiency in postpartum anemic women (chapter 6), since these 
markers are not affected by the acute phase response [40].




In order to prevent iron deficiency anemia, the WHO recommends universal 
supplementation with iron and folic acid for 6 months during pregnancy [3, 33]. In areas 
with high prevalence (≥ 40%) of anemia in pregnant women, supplementation should 
be continued to the postpartum period to enable women to acquire adequate iron 
stores [3]. The Dutch guideline recommends treatment of anemia during pregnancy 
and the postpartum period with oral iron supplementation in iron deficiency anemia, 
and folic acid supplementation in folic acid deficiency anemia [41]. As previously 
mentioned, postpartum anemia is diagnosed based on Hb level alone [25, 35, 36]. In 
daily practice, both oral iron and folic acid are subscribed to treat postpartum anemia 
[42]. However, in the current literature it is unknown whether the addition of folic acid 
to oral iron supplementation is effective in the treatment of postpartum anemia. A 
randomized controlled trial in this thesis compared Hb level, HS, and fatigue after 
treatment of postpartum anemic women with oral iron supplementation or with oral 
iron and folic acid supplementation (chapter 7). 
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Aims of the thesis
Micronutrient deficiency is a common problem, which can worsen during pregnancy 
into the postpartum period. Deficiencies of the micronutrients iron, folic acid or 
vitamin B12 could result in anemia. Anemia and vitamin D deficiency were found to 
be associated with impaired HS and QOL [7, 8, 10], and increased fatigue [9, 11, 12]. 
However, maternal HS and fatigue in association with micronutrient deficiency is a 
neglected topic. 
We intended to answer the following questions in this thesis:
• What are the HS and QOL in postpartum women and what factors contribute to 
this? (Chapter 2)
• What is the difference in HS and fatigue between anemic and non-anemic 
women during the first 5 weeks postpartum? (Chapter 3)
• What is the prevalence in vitamin D insufficiency in postpartum women, and is 
there an association with infant feeding method, HS, and fatigue? (Chapter 4)
• What is the course of vitamin B12 deficiency in the postpartum period? Does a 
shift occur towards holoTC in postpartum women with insufficient available total 
vitamin B12? (Chapter 5)
• Is it useful to measure MCV and CHr to identify truly iron deficient women with 
postpartum anemia? (Chapter 6)
• Is there an additional benefit in the treatment of postpartum anemia when folic 
acid is added to oral iron supplementation in order to improve Hb level and HS, 
and to reduce fatigue? (Chapter 7) 
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Chapter 2
Health status and quality of life in 
postpartum women: a systematic 
review of associated factors
D.A.A. van der Woude, J.M.A. Pijnenborg, J. de Vries
European Journal of Obstetrics & Gynecology and Reproductive Biology 2015;185:45-52




Since health care is becoming more and more patient centered, patient-reported 
outcomes such as quality of life (QOL) and health status (HS) are becoming 
increasingly important. The aim of this systematic review was to provide an overview 
of physical, psychological, and social domains of QOL and HS in postpartum women, 
and to assess which factors are associated with QOL and HS domains postpartum.
A computerized literature search was performed using the PubMed, PsycINFO, and 
Cochrane databases. Studies were selected if the three domains of QOL or HS were 
measured in a (sub)group of postpartum women, by using validated standardized 
questionnaires.
The methodological quality of the 66 included studies was examined by two 
independent reviewers.
All three domains of QOL were impaired in postpartum women with urinary 
incontinence, with even worse QOL in women with mixed urinary incontinence. 
Mental QOL was impaired in women with urge urinary incontinence after cesarean 
section. Social QOL was decreased in HIV-positive women. HS was impaired in all three 
domains in postpartum depressed women. Physical HS was impaired after cesarean 
section for at least two months postpartum. Additional supportive interventions from 
health care or social support were not associated with improved HS. 
Urinary incontinence and being HIV-positive seemed to be associated with impaired 
QOL. Postpartum depression and a cesarean section seemed to be associated with 
impaired HS. Prospective longitudinal research is needed in order to draw valid 
conclusions regarding postpartum HS and QOL, and the predictive value of the 
associated factors. 
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Introduction
Worldwide, 255 women give birth to a child every minute [1]. The postpartum period, 
or puerperium, is considered to start one hour after delivery and is traditionally 
supposed to end six weeks after birth as it was believed that the body of the woman has 
then returned to the non-pregnant state [2]. However, a number of health conditions 
last even more than two years postpartum [3]. The postpartum period is characterized 
by several physical and mental health problems. The most common problems 
are urinary and fecal incontinence, infection, sexual problems, breast problems, 
anemia, wound problems, headache, backache, constipation, hemorrhoids, fatigue, 
depression, and anxiety [2-4]. These health problems can lead to sick leave and long-
term sickness absence from work [5]. Since postpartum women have to cope with all 
these changes, their quality of life (QOL) and health status (HS) can be impacted [6]. 
QOL and HS are important categories of patient-reported outcomes (PROs), in which 
the patients perspective is key, and that can be used to assess the impact of current HS 
and to assess the efficiency of interventions [7]. The difference between these PROs is 
that where HS refers to self perceived physical, psychological and social functioning, 
QOL also incorporates patients’ evaluation of functioning, i.e. (dis)satisfaction with these 
aspects of life [7]. Since health care is becoming more and more patient centered, the 
assessment of the patient’s subjective experience is considered to be essential for 
informed clinical decision-making and health policy [8]. Therefore, research on QOL 
and HS in postpartum women is increasing, in which multiple contributing factors 
and interventions are examined. 
The objective of this systematic review was to provide an overview of the core domains 
(physical, psychological, and social) of QOL and HS in postpartum women after the 
birth of a live infant, and to assess which factors are associated with QOL and HS 
domains postpartum.




Sources and selection criteria
A two-step literature search was conducted on 29 July 2014 using the PubMed, 
PsycINFO, and Cochrane databases. First, the following keywords and Boolean 
operators were used: (maternal OR women OR mothers) AND (postpartum OR 
postnatal OR puerperium) AND (health status OR quality of life). No limit was set with 
regard to publication date. The search was performed according to the guidelines of 
the Cochrane Collaboration [9]. Second, the reference lists of relevant articles were 
consulted and articles were added if they met the inclusion criteria. 
All studies that met the following criteria were included: (1) QOL or HS was (part of) 
the outcome; (2) results included at least the physical, mental, and social domains of 
QOL or HS; (3) the study population included a (sub)group of postpartum women; 
(4) the article was a full report (no case report, editorial, poster text, letter or review) 
published in English, Dutch, or German; (5) HS or QOL were measured using 
standardized validated questionnaires; (6) studies were published in peer reviewed 
journals. Since QOL and HS should at least include the physical, mental and social 
domains, studies were excluded if they lacked one of these domains [10, 11]. Studies 
were also excluded if they only reported a total score for QOL and/or HS without 
reporting the scores of the different domains, to be sure that the three domains were 
measured. 
Quality assessment
Each study was evaluated for quality and risk of bias using a standardized systematic 
review checklist of 18 predefined criteria by two reviewers independently (DW and 
JDV or DW and JP). The checklist was based on established criteria for systematic 
reviews and on established criteria for reviewing QOL studies [12-18].These criteria are 
presented in Table 1. One point was assigned to each item which met a criterion. If an 
item did not meet a particular criterion, was described insufficiently, or not at all, no 
point was assigned. As a result, the scores for each article can range from 0 to 18 points. 
Disagreement about the quality of studies was solved through open discussion. The 
quality scores of the included articles are presented in Table S1.
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Table 1 Criteria for assessing the methodological quality of studies
Positive if with respect to
QOL assessment
A.  A description is given of QOL and/or HS by (i) describing at least the domains and/or (ii) indicating 
that QOL/HS reflects the subjective experience of the patient
B. A reason is given for choosing a certain questionnaire
C. A distinction is made between QOL and HS
Study population
D. The study describes its ethical approval (e.g. ethics committee or institutional review board, etc)
E.  A description is included of at least two socio-demographic variables (e.g. age, sex, employment 
status, education status, etc.)
F.  A description is present of at least two clinical variables (e.g. duration of symptoms, use of 
medication, etc)  
G. Inclusion and/or exclusion criteria are provided
H.  The study describes potential prognostic factors by using multivariate analysis or structural 
equation modeling
I. Participation rates for patient groups are described and these rates are exceeding 75%
J. Information is given about the non-responders versus responders
Study design
K. The study size is consisting of at least 50 patients (arbitrarily chosen) 
L. The collection of data is prospectively gathered
M. The design is longitudinal (more than one year)
N. The process of data collection is described (e.g. interview or self report, etc)
O. The follow up period is at least 6 months 
P. The lost to follow-up is < 20%
Results
Q.  The results are compared between two groups or more (e.g. health population, groups with 
different age) and/or results are compared with at least two time points (e.g. longitudinally or pre- 
versus post-treatment)
Outcome measures 
R. A psychometrically sound QOL or HS questionnaire is used
Studies scoring ≥ 12 points were considered to be of “high quality”, studies scoring 
between 9 and 12 points were considered to be of “moderate quality”, and studies 
scoring < 9 points were considered to be of “low quality’’. This scoring system is based 
on previously published reviews regarding QOL and HS, and helps to weigh the 
impact of the results with the quality of the included studies [14-16, 19, 20]. Studies 
with higher scores, weigh more in processing the results. Therefore, if only one article 
displays a certain association, this does not mean that evidence for this association 
exists. When studies reported results of the same patient sample, only the highest 
quality study was included.
Data extraction and analysis
DW performed the data extraction and summarized the following variables in Tables 
S2a (QOL) and S2b (HS): study design, study size and population, intervention (if 
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appropriate), time of postpartum measurement, and results. When in doubt, JDV or 
JP were accessible for consultation.
Findings were considered consistent if ≥ 75% of the studies in which a particular 
factor was investigated showed the same direction of the association. We defined 
four levels of evidence which we used to describe the results: strong, moderate, weak, 
and inconclusive evidence (Table 2). This was based on previously published reviews 
regarding QOL and HS [14-16, 19, 20]. If less was published on a particular topic, the 
evidence was considered insufficient. The insufficient evidence was not processed in 
the results section of this review, but can be found the summary tables S2a and S2b. 
The results were presented by PRO (QOL or HS) and subcategorized in the physical, 
mental and social domains. 
Table 2 Level of evidence
Strong Consistent findings in at least two high-quality studies or 
consistent findings in one high-quality study and at least three moderate-quality studies
Moderate Consistent findings in one high-quality study and at least one low-quality study or 
consistent findings in at least three moderate-quality studies
Weak Consistent findings in two moderate-quality studies or 
consistent findings in at least three or more low-quality studies
Inconsistent Inconsistent findings irrespective of study quality 
Results
Study selection
The process of study selection is presented in Figure 1. The first literature search step 
identified 4,421 articles. After eliminating duplicates (n = 315) and triples (n = 12), 
4,082 articles remained. The titles and abstracts of the 4,082 articles were screened 
and evaluated for eligibility by the first author (DW). The inclusion and exclusion 
criteria were applied to the abstracts, resulting in 3,935 excluded articles. If in doubt, 
the article was read in its entirety. Of the remaining 146 articles, one was not available 
in full text. This article was provided to us by the corresponding author [21]. After 
reading the 146 articles, 62 articles fulfilled the selection criteria in agreement with 
JDV. To decrease risk of bias in processing the results, one study was excluded because 
the results of the same patient sample were reported [22]. The hand search of the 
reference lists resulted in five additional articles [23-27]. A total of 66 articles were 
included in this review.  
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Figure 1 Process of study selection
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Articles excluded based on 
inclusion criteria n=85 
(1) QOL or HS was (part of) the 
outcome n=3 
(2) Results included the three 
domains of QOL or HS n=66 
(3) A (sub)group of postpartum 
women was included n=1 
(4) The article was a full report in 
English, Dutch, or German n=7 
(5) Standardized validated 
questionnaires were used n=4 
(6) Studies were published in 
peer reviewed journals n=0 
(2) and (5) n=4 
Study characteristics
The included studies were conducted between 1996 and May 2014. Twenty-three 
studies claimed to measure QOL but measured HS. Their results were summarized in 
the HS table (Table S2b). Twenty-four studies measured QOL [6, 21, 28-49], 40 studies 
measured HS [23-27, 50-84], and two studies measured both [85, 86]. The studies were 
heterogeneous with regard to sample size, timing of first postpartum assessment, and 
interventions or factors examined. None of the studies used healthy fertile women as 
a comparison group. 
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Five validated HS questionnaires and 12 validated QOL questionnaires were used 
in the included studies (Table S3). The Medical Outcomes Study 36 Item Short Form 
Health Survey (SF-36) was most commonly used to measure HS (35 studies) and 
the World Health Organization Quality of Life Assessment-Bref (WHOQOL-Bref) 
was most commonly used to measure QOL (10 studies). The Incontinence Impact 
Questionnaire (IIQ) or Incontinence Impact Questionnaire short form (IIQ-7) was the 
most frequently used disease-specific questionnaire (five studies).
The quality scores ranged from 6 to 14 points (mean ± standard deviation: 10.7 ± 1.7). 
Twenty-three studies (35%) were considered to be of high quality, 35 studies (53%) 
were considered to be of moderate quality, and eight studies (12%) were considered to 
be of low quality. Methodological shortcomings mainly concerned the poor distinction 
made between QOL and HS (n = 6), the low number of longitudinal studies (n = 7), and 
often no information is given about the non-responders versus responders (n = 13).
Quality of life in postpartum women
Physical quality of life
Weak evidence was found for the lack of an association between mode of delivery and 
physical QOL in postpartum women, since there was no difference between scores 
after a cesarean section and vaginal delivery [40, 41]. Strong evidence was found for 
the lack of an association between physical QOL and the mode of delivery (vaginal 
delivery or cesarean section) in postpartum women with stress urinary incontinence 
[30, 33]. Weak evidence was found for an impairment in physical QOL in postpartum 
women with urinary incontinence, but these studies did not use a comparison 
group [32, 35, 86]. Also, weak evidence showed that mixed urinary incontinence in 
postpartum women was associated with worse physical QOL scores when compared 
to only stress- or urge urinary incontinence in these women [21, 86]. 
Mental quality of life
Moderate evidence was found for reduced mental QOL scores in postpartum women 
with urinary incontinence, without using a comparison group [25, 55, 70, 71]. Strong 
evidence was found for the lack of an association between mental QOL and mode of 
delivery in postpartum women with stress urinary incontinence [30, 33]. There were 
no differences in mental QOL scores after a vaginal delivery or cesarean section. 
Strong evidence was found for the association of mental QOL and mode of delivery 
in women with urge urine incontinence [30, 33]. Postpartum women with urge urine 
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incontinence after a cesarean section reported worse mental QOL when compared to 
women with urge urine incontinence after a vaginal delivery. Weak evidence showed 
that postpartum women with mixed urinary incontinence reported worse mental 
QOL scores when compared to postpartum women with only stress- or urge urinary 
incontinence [21, 86]. 
Inconsistent evidence exists with regard to mode of delivery and mental QOL 
postpartum. One study found no difference in mental QOL scores in postpartum 
women after a cesarean section and vaginal delivery [40]. Another study found worse 
mental QOL scores in postpartum women after a cesarean section compared to after 
a vaginal delivery, but this just reached significance (p = 0.047) [41].
Social quality of life
Without using a comparison group, weak evidence was found for reduced social QOL 
scores in postpartum women with urinary incontinence [32, 35, 86]. Strong evidence 
was found for the lack of an association between mode of delivery (vaginal delivery 
and cesarean section) and social QOL in postpartum women with stress urinary 
incontinence [30, 33]. Weak evidence showed that mixed urinary incontinence in 
postpartum women was associated with worse social QOL scores when compared to 
only stress- or urge urinary incontinence [21, 86]. Moderate evidence was found for 
the association of social QOL and the human immunodeficiency virus (HIV). HIV-
positive postpartum women scored worse on social QOL compared with HIV-negative 
postpartum women [43, 44]. 
Inconsistent evidence was found with regard to mode of delivery and social QOL 
postpartum. One study found worse postpartum social QOL in women after a 
cesarean section compared to women after a vaginal delivery [41], but another study 
found no difference [40].
Health status in postpartum women
Physical health status
Strong evidence was found for the association of physical HS and mode of delivery. 
Postpartum women after a cesarean section reported worse physical HS compared to 
women after a vaginal delivery for at least two months postpartum [51, 53, 64, 65, 78]. 
Moderate evidence showed that depressed postpartum women scored significant 
worse on the SF-36 scales vitality and role limitations due to physical health compared 
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to normative means [25, 55]. Also, weak evidence showed that depressed postpartum 
women scored worse on the physical component summary of the SF-36 compared 
to postpartum women without depression [69-71]. Moderate evidence found no 
association of physical HS and additive supportive interventions from health care. 
Three randomized controlled trials found no improvement in any of the physical SF-
36 scales after adding supportive interventions from health care [73-75].
Inconsistent evidence was found with regard to physical health change in healthy 
women from pregnancy to postpartum. Four studies found improvement of physical 
functioning [51, 52, 60, 61], but one found no difference [54]. Also, inconsistent evidence 
exists on pelvic muscle exercises for persistent pelvic pain in postpartum women and 
physical HS. Two randomized controlled trials compared the pelvic muscle exercises 
to standard care. One of these trials found no improvement of physical HS after 
exercise [27], but the other trial did find an improvement after exercise, even after two 
years of follow-up [76, 77]. 
Mental health status
Moderate evidence showed that depressed postpartum women scored worse on all 
SF-36 mental health scales compared to normative means [25, 55]. Also, weak evidence 
showed that women with postpartum depression scored worse on all SF-36 mental 
health scales, including the mental component summary, compared to women without 
postpartum depression [69-71]. Moderate evidence from three randomized controlled 
trials showed that postpartum mental HS was not influenced by additive supportive 
interventions from health care. None of the SF-36 mental scales improved [73-75].
Inconsistent evidence was found with regard to mental health change in healthy women 
from pregnancy to postpartum. Three studies found improvement of mental health 
[51, 54, 61], but two studies found no difference [52, 60]. Also, inconsistent evidence was 
found for the association of mode of delivery and mental HS. At six weeks postpartum, 
one study found worse mental health after an elective cesarean section compared with 
a vaginal delivery, but found no difference comparing an emergency cesarean section 
with a vaginal delivery [64]. Three studies found worse mental health after a cesarean 
section compared with a vaginal delivery at four to 38 weeks postpartum [55] between 
six to eight weeks postpartum [78], and at four months postpartum [65], Three studies 
found no difference in mental HS between 24 and 48 hours postpartum [53], between 
one and two weeks postpartum [53], at two months postpartum [65], and between 12 
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and 14 weeks postpartum [78]. Inconsistent evidence was found for the effect of pelvic 
muscle exercises in postpartum women with persistent pelvic pain on mental HS. One 
randomized controlled trial found no difference in mental HS after exercise compared 
to standard care [27]. Another randomized found an improvement of mental HS 
after exercise, even after two years of follow-up [76, 77]. For the association of abuse 
of postpartum women and mental HS, inconsistent evidence exists. One study found 
worse mental HS in abused postpartum women compared to non-abused postpartum 
women [67]. The abuse consisted of physical, psychological, or sexual abuse, but could 
also consist of a combination of abuses. Another study found only worse mental HS 
in postpartum women experiencing both psychological and physical abuse compared 
to non-abused postpartum women [68]. Women experiencing only psychological 
or physical abuse did not differ with regard to mental HS compared to non-abused 
women [68]. Furthermore, inconclusive evidence was found with regard to parity and 
mental HS. One study found that having a greater number of children was negatively 
related to mental health [24]. However, another study found no association between 
parity and mental health [55].
Social health status
Moderate evidence showed that postpartum depressed women scored worse on 
the SF-36 social functioning scale compared to normative means [25, 55]. Also, weak 
evidence showed that women with postpartum depression scored worse on the SF-
36 social functioning scale compared to women without postpartum depression [69-
71]. Moderate evidence showed that adding supportive interventions from health 
care was not associated with social HS in postpartum women. Three randomized 
controlled trials found no improvement on the SF-36 social functioning scale after 
adding supportive interventions from health care [73-75].
Inconclusive evidence was found with regard to social health change in healthy 
women from pregnancy to postpartum. One study found improvement of social 
health [51], two studies found impairment of social health [52, 54], and two studies 
found no difference [60, 61]. Inconclusive evidence exists on pelvic muscle exercises 
for persistent pelvic pain in postpartum women and social HS. An improvement of 
social HS was found in one randomized controlled trial [76], and in their follow-up 
study after two years [77]. Another randomized controlled trial found no difference in 
social HS comparing the pelvic muscle exercises to standard care [27]. Evidence on the 
association between abuse and postpartum social HS was also inconclusive. Social HS 
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was impaired in abused postpartum women compared to non-abused postpartum 
women in one study [67]. However, another study found that social HS was only 
impaired in postpartum women experiencing both psychological and physical abuse 
compared to non-abused postpartum women [68]. 
Discussion
All three QOL domains were impaired in postpartum women with urinary 
incontinence, with worse impairment in mixed urinary incontinence compared 
to stress and urge urinary incontinence. Impairment of mental QOL seemed to be 
associated with urge urinary incontinence after cesarean section. Social QOL seemed 
to be decreased in HIV-positive women. QOL seemed not to be associated with mode 
of delivery in postpartum women with stress urinary incontinence. HS seemed to be 
impaired in all three domains in postpartum depressed women. Physical HS seemed 
to be impaired after a cesarean section for at least two months postpartum. Additional 
supportive interventions from health care improved none of the HS domains. 
In present review, urinary incontinence in postpartum women was found to be 
associated with impaired QOL in all three domains. This corresponds to a consensus 
in the literature that urinary incontinence affects QOL in women [87, 88]. Urinary 
incontinence was earlier found to affect physical and psychological wellbeing, but also 
socio-economical and sexual aspects of women [89, 90]. As in the current literature, 
mixed urinary incontinence was found to have a higher impact on QOL than stress or 
urge incontinence [90-92]. This probably has to do with the fact that these women 
experience coexisting symptoms of stress and urge urinary incontinence and have 
more severe urinary incontinence [91, 92]. 
After a cesarean section, urge urinary incontinence was associated with impaired 
mental QOL compared to women after a vaginal delivery. At the same time, the mode 
of delivery in postpartum women with stress urinary incontinence was not associated 
with QOL. Maybe, women after a cesarean section have different expectations than 
after a vaginal delivery, which can explain these results [33]. 
HIV-positivity was associated with impairment in social QOL in postpartum women. 
HIV patients have to cope with the fear of stigma and discrimination [93]. HIV-positive 
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women are particularly vulnerable to rejection and the loss of important familial and 
social relationships [94, 95]. 
All three domains of HS were impaired in women with postpartum depression 
compared to women without postpartum depression and to normative means. This 
corresponds to a number of symptoms associated with the Diagnostic and Statistical 
Manual of Mental Disorders (DSM) criteria for postpartum depression, such as 
loss of energy or fatigue, depressed mood, and loss of interest or pleasure [96]. The 
impairment in social functioning fits the DSM criterion that these symptoms must 
cause clinically significant distress or impairment in social, occupational, or other 
important areas of functioning [96].
As expected, physical HS was impaired in women after a cesarean section. Physical 
recovery takes time after surgery, such as a cesarean section, and could be hindered 
by pain and reduced mobility [97].
The current review found no association of additional supportive interventions from 
health care with improved HS in all three domains. This corresponds to a systematic 
review examining the effect of additional social support and postpartum care on 
postpartum HS [98].
The strength of this review is that it includes all studies examining the core domains 
of QOL and HS in postpartum women as defined by the World Health Organization 
(WHO); physical, mental, and social domain [10, 11]. 
Some limitations of our review should be acknowledged. First, because the present 
review is a systematic review and not a meta-analysis, the quality of the included 
studies is the most important to weigh the impact of the results. The scoring system 
used is based on previously published reviews regarding QOL and HS [14-16, 19, 20]. 
Data were pooled by the quality of the included studies. Therefore, no statement 
can be made about the magnitude of the results. Secondly, a range of different 
questionnaires were used to measure QOL or HS. However, most HS studies used the 
SF-36 and most QOL studies used the WHOQOL-Bref or IIQ. Finally, publication bias 
can be present. However, the results on the different domains can differ, which makes 
it more likely that no publication bias is present. 
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In conclusion, urinary incontinence and being HIV-positive seemed to be associated 
with impaired QOL. Postpartum depression and a cesarean section seemed to be 
associated with impaired HS. Additional supportive interventions from health care 
were not associated with improved HS. 
Prospective longitudinal research with healthy and demographic matched controls is 
needed in order to draw valid conclusions regarding postpartum HS and QOL, and the 
predictive value of the associated factors. In order to ensure comparability, all studies 
must use the same validated instruments.
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Objective: The incidence of postpartum anemia is high. Current therapy consists of 
iron supplementation or blood transfusions, based on the assumption that these 
treatments improve health status (HS) and reduce fatigue. The aim of this study was 
to compare HS and fatigue in postpartum women with and without anemia.
Study design: This prospective cohort study was performed in The Netherlands 
between April 2008 and August 2010 and involved 112 anemic (hemoglobin [Hb] < 10.5 
g/dL) and 108 non-anemic (Hb ≥ 10.5 g/dL) women. The anemic women received oral 
iron supplementation. Within 48 hours and 5 weeks after delivery, HS was measured 
using the 36 item Short-Form Health Survey (SF-36) and fatigue was measured using 
the Checklist Individual Strength (CIS). ANOVA for repeated measures was used to 
compare HS and fatigue scores among groups and across time.
Results: After adjustment for confounding variables, there were no interaction effects 
in any of the HS and fatigue scores. SF-36 physical functioning (p < 0.0001), social 
functioning (p = 0.025) mental health (p = 0.043), vitality (p = 0.001), bodily pain (p 
= 0.01), physical component summary (p < 0.0001), mental component summary 
(p = 0.02), and total scores (p < 0.0001), and the CIS subscales subjective fatigue (p 
< 0.0001), motivation (p < 0.0001), activity (p = 0.005), and total scores (p < 0.0001) 
improved across time. No significant differences between the anemic and non-
anemic group were observed. Regression analyses showed no association of anemia 
and the amount of blood loss with any of the SF-36 and CIS scales at both time points, 
but did show that cesarean section was associated with lower physical HS on both 
time points. 
Conclusion: HS and fatigue were not different among women with and without 
postpartum anemia.
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Introduction
Postpartum anemia is a worldwide problem with a prevalence ranging from 22% to 
50% in developed countries and from 50% to 80% in developing countries [1]. Major 
causes of postpartum anemia include pre-existing iron deficiency and iron deficiency 
anemia (IDA) in combination with excessive blood loss during delivery [2]. Ferritin, a 
marker used to diagnose IDA, is not useful in the early postpartum period because 
of its prominent role in the acute phase response during parturition [3,4]. Therefore, 
the definition and indication for the treatment of postpartum anemia are based on 
hemoglobin (Hb) level [3,5,6]. 
Fatigue is considered the major symptom of anemia [7]. This type of fatigue is not 
an isolated physical symptom, but involves lethargy, decreased mental alertness, 
physical weakness, and poor concentration [8]. Uncorrected IDA may have a negative 
impact on maternal cognition, mood and behavior, and could thereby alter mother-
child interactions [9,10]. Therefore, health status (HS), a multidimensional concept 
that incorporates the self-perceived functioning of physical, psychological, and social 
aspects of life [11], is regarded as reduced in women with postpartum anemia [1].
To date, few studies have compared HS and fatigue between women with and 
without postpartum anemia. An observational study examined the natural course of 
HS and fatigue during the first 6 postpartum weeks in relation to mode of delivery 
[12]. In addition to physical HS being significantly poorer after a cesarean section than 
after a vaginal delivery, Hb level was found to be negatively correlated with physical 
HS and fatigue immediately postpartum. This correlation had disappeared 1 week 
postpartum. If necessary, women were treated postpartum with oral iron and folic 
acid. To our knowledge, however, HS and fatigue scores have not been compared in 
women with and without postpartum anemia.
In the present study, we examined differences in HS and fatigue between anemic 
and non-anemic women during the first 5 weeks postpartum. We also investigated 
changes in HS and fatigue over time. Furthermore, regression analyses were 
performed to assess the effect of anemia, the amount of blood loss, and mode of 
delivery on HS and fatigue. 




The current prospective cohort study was performed between April 2008 and August 
2010 at a large teaching hospital in Tilburg, in the southern part of The Netherlands. 
The threshold for the definition of anemia in the early postpartum period varies 
between < 11.0 g/dL and < 10.0 g/dL [1,3]. Anemia in the current study was defined 
according to the Dutch guidelines as Hb concentration < 10.5 g/dL [5]. The anemic 
women were part of a randomized controlled trial that showed no between-group 
differences in Hb, HS, and fatigue after receiving oral iron supplementation with and 
without folic acid [13]. Non-anemic women (Hb ≥ 10.5 g/dL) received no treatment 
and were followed prospectively during the study.
Women were eligible for inclusion if they were ≥ 18 years old, thoroughly understood 
the Dutch language, and had indications for Hb determination within 48 hours 
after delivery, including estimated blood loss > 500 ml, delivery by cesarean section, 
manual removal of the placenta, and clinical symptoms of anemia.
Women were excluded if: their Hb was < 6.4 g/dL (because the hospital protocol 
indicates the need for packed red cell transfusion); they were addicted to alcohol 
or drugs; they had hematological diseases such as hemoglobinopathies, sickle cell 
disease, thalassemia, and Hemolysis Elevated Liver enzymes and Low Platelets 
syndrome (HELLP); they had vitamin B12 deficiency (serum vitamin B12 < 100 nmol/L 
and holotranscobalamine < 20 pmol/L); they had chronic inflammatory disease; they 
were being treated with methotrexate; or they had contra-indications to treatment 
with folic acid or ferrous fumarate.
The study protocol was approved by the local ethics committee (file number 
NL21797.028.08). All women received oral and written information about the study, 
and provided oral and written informed consent.
Maternal venous blood was collected and questionnaires to assess HS and fatigue 
were completed within 48 hours postpartum (T0) and again at the outpatient clinic 5 
weeks after delivery (T5). The outcome measures were HS and fatigue improvement 
among groups and across time.
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Hb was analyzed using an Advia 2120i automated cell counter (Siemens Healthcare 
Diagnostics, Breda, The Netherlands). Hb, measured as mmol/L, was converted to 
g/dL by multiplying by 1.6115. 
HS was measured using the self-reported standardized 36 item Short-Form Health 
Survey (SF-36), a generic questionnaire that was chosen because it covers all HS 
domains and is often used in determining HS in postpartum women, allowing good 
comparability among studies. The 36 items are organized into eight scales: physical 
functioning, role physical, bodily pain, general health, vitality, social functioning, 
role emotional, and mental health. Each item has a scoring range from 0 to 100, with 
higher scores representing better levels of functioning [14]. In addition, the SF-36 
provides a physical component summary (PCS) and a mental component summary 
(MCS). The SF-36 has demonstrated good psychometric properties in postpartum 
women [15]. 
Fatigue was measured using the Checklist Individual Strength (CIS), a 
multidimensional scale that quantifies subjective fatigue and related behavioral 
aspects [16]. This questionnaire was chosen because fatigue is a symptom of anemia. 
The 20 items cover four dimensions: subjective experience of fatigue, reduced 
concentration, reduced motivation, and reduced physical activity level. Each item has 
a scoring range from 1 to 7, with higher scores indicating greater fatigue. The CIS has 
been shown reliable and valid in patients with chronic fatigue syndrome, as well as in 
healthy populations [17].
Statistical analyses were performed using SPSS 15.0. Baseline differences between 
the anemic and non-anemic women were assessed with independent sample T-tests, 
Mann-Whitney U tests or Chi-square tests. ANOVA for repeated measures were used 
to compare HS and fatigue scores among groups and across time. We corrected for the 
number of tests using the Bonferroni rule. Potential baseline differences and mode of 
delivery (vaginal/cesarean section) were entered as covariates, since cesarean section 
has been shown to affect physical HS [12]. We report both the unadjusted and adjusted 
results, to show the impact of these covariates. To make a more comprehensive 
assessment of the effect of anemia, the amount of blood loss, and mode of delivery on 
HS and fatigue, linear regressions (method: enter) were performed with the SF-36 and 
CIS subscales as dependent variables. Results are reported as the mean ± standard 
deviation (SD), mean ± standard error of the mean (SEM), or percentage (%), as 
appropriate. A p-value less than 0.05 was considered statistically significant.




Of the 364 women screened, 53 did not meet the inclusion criteria, including 42 with 
vitamin B12 deficiency, eight with Hb < 6.4 g/dL, and three due to a language barrier. 
Eleven women declined to participate. Eighty women did not complete the baseline 
HS questionnaires for unknown reasons and were therefore excluded.
A total of 220 women were included in the study, including 112 with anemia and 108 
without anemia. A total of 50 participants were lost to follow-up after repeatedly 
not showing up for follow-up appointments. Eight withdrew before the follow-up 
appointment, mostly because of a lack of time. Thus, 91 anemic women and 71 non-
anemic women were analyzed (Figure 1).








































♦      Lost to follow-up (no-
show) (n=32) 
♦      Withdrawal (time 
shortage) (n=5) 
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• vitamin B12 deficient (n=42) 
• Hb < 6.4 g/dL (n=8) 
• language barrier (n=3)  
♦      Declined to participate (n=11) 
♦      Incomplete HS questionnaires (n=80) 
Assessed for eligibility  
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The demographic and clinical characteristics of the participants at baseline are shown 
in Table 1. The method of delivery differed significantly among the groups, with 
cesarean sections performed in 37.5% of the women with anemia and 71.3% of non-
anemic women (p < 0.013). As expected, blood loss was significantly greater in anemic 
than in non-anemic women (p < 0.0001). 





Age at entry (years) 30.6 ± 4.7 31.4 ± 4.0
BMI before pregnancy (kg/m2) 25.2 ± 5.4 25.4 ± 5.6
Twin pregnancies 4 (3.6) 1 (0.9)
Ethnicity 
   Caucasian 97 (86.6) 97 (89.9)
   Turkish 5 (4.5) 7 (6.5)
   African 5 (4.5) 2 (1.9)
   Asian 3 (2.7) 0 (0.0)
   South American 2 (1.8) 2 (1.9)
Highest education
   Lower 6 (5.6) 1 (1.0)
   Medium 56 (52.3) 50 (47.6)
   High 45 (42.1) 54 (51.4)
Smoking 15 (13.5) 7 (6.5)
Multivitamin use 45 (40.2) 54 (50.0)
Parity at baseline 1.5 ± 0.8 1.6 ± 0.7
Gestational age at delivery (weeks) 40.0 ± 1.5 39.7 ± 1.4
Delivery method a
   Vaginal 70 (62.5) 31 (28.7)
   Cesarean section 42 (37.5) 77 (71.3)
      Elective cesarean section 12 (28.6) 43 (55.8)
      Emergency cesarean section 30 (71.4) 34 (44.2)
Estimated blood loss (ml) b 824 ± 416 505 ± 280
Infant feeding
   Breastfeeding 70 (62.5) 75 (69.4)
   Bottle (formula) feeding 42 (37.5) 33 (30.6)
Numbers are mean ± SD or number (percentage).
BMI = Body Mass Index (calculated as weight in kilograms divided by the square of height in meters).
a Chi square: p = 0.013 between vaginal delivery and cesarean section, p < 0.0001 between vaginal delivery, 
elective cesarean section, and emergency cesarean section.
b Mann-Whitney U test: p < 0.0001.
Note: There were no significant differences between anemia versus non-anemia on the other variables.
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Analysis of results on the SF-36 and CIS showed that, without adjusting for baseline 
differences (including delivery method), there were no interaction effects (Table 2). 
However, an effect of time was observed with regard to the SF-36 subscales physical 
functioning, social functioning, role physical, mental health, vitality, bodily pain, PCS, 
MCS, and total scores (p < 0.0001) and the CIS subscales subjective fatigue, motivation, 
and activity, and total scores (p < 0.0001). All scores improved. Also, a group effect for 
the SF-36 physical functioning scale (p = 0.008) and PCS (p = 0.046) was found. The 
anemic group scored higher compared with the non-anemic group. 
Table 2 Health status and fatigue by group at baseline (T0) and at 5 weeks postpartum (T5) a
Anemia No anemia
T0 T5 T0 T5
SF-36
   Physical functioning 41.5 ± 3.5 82.0 ± 1.9 30.0 ± 4.0 75.9 ± 2.2
   Social functioning 67.7 ± 2.8 85.0 ± 2.2 63.8 ± 3.2 78.2 ± 2.5
   Role physical 34.4 ± 4.0 69.4 ± 4.4 32.2 ± 4.5 55.4 ± 5.0
   Role emotional 85.4 ± 3.5 91.4 ± 3.9 81.9 ± 4.0 89.2 ± 4.5
   Mental health 78.9 ± 1.6 86.3 ± 1.3 76.8 ± 1.8 84.9 ± 1.5
   Vitality 54.7 ± 2.1 66.1 ± 2.6 55.6 ± 2.4 65.4 ± 3.0
   Bodily pain 60.2 ± 3.1 84.2 ± 2.1 55.8 ± 3.6 80.8 ± 2.4
   General health 80.1 ± 1.5 79.9 ± 1.7 78.4 ± 1.7 76.5 ± 1.9
   Health change 44.8 ± 2.1 46.4 ± 2.0 46.8 ± 2.4 44.4 ± 2.3
   PCS 53.9 ± 2.3 78.9 ± 2.0 49.4 ± 2.6 72.7 ± 2.3
   MCS 71.5 ± 1.8 82.7 ± 1.9 69.4 ± 2.1 79.4 ± 2.1
   Total 60.8 ± 1.7 76.9 ± 1.6 57.8 ± 1.9 72.7 ± 1.8
CIS
   Subjective fatigue 35.2 ± 1.3 26.2 ± 1.2 34.8 ± 1.5 29.0 ± 1.3
   Reduced motivation 13.1 ± 0.6 8.6 ± 0.4 13.3 ± 0.7 9.9 ± 0.5
   Reduced activity 11.8 ± 0.6 8.1 ± 0.5 12.3 ± 0.6 9.3 ± 0.5
   Reduced concentration 15.0 ± 0.8 13.4 ± 0.8 15.4 ± 0.9 14.6 ± 0.9
   Total 74.8 ± 2.7 56.4 ± 2.3 75.0 ± 3.1 62.8 ± 2.6
Numbers are mean ± SEM
SF-36 = 36 item short-form health survey, PCS = Physical component summary, MCS = Mental component 
summary, CIS = Checklist individual strength.
a Repeated measures ANOVA, without adjustments for baseline differences (mode of delivery and estimated 
blood loss)
After adjustment for baseline differences, including delivery method, there was 
also no interaction effect (Table 3). However, there was an effect of time for the SF-
36 subscales physical functioning (p < 0.0001), social functioning (p = 0.025), role 
physical (p = 0.002), mental health (p = 0.043), vitality (p = 0.001), bodily pain (p 
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= 0.01), PCS (p < 0.0001), MCS (p = 0.02), and total scores (p < 0.0001), and the CIS 
subscales subjective fatigue (p < 0.0001), motivation (p < 0.0001), activity (p = 
0.005), and total scores (p < 0.0001). All scores improved. On average, there were no 
significant differences between the anemic and non-anemic group. 
Table 3 Adjusted health status and fatigue by group at baseline (T0) and at 5 weeks postpartum (T5) a
Anemia No anemia
T0 T5 T0 T5
SF-36
   Physical functioning 36.8 ± 3.5 79.4 ± 1.9 36.8 ± 4.0 79.2 ± 2.2
   Social functioning 65.8 ± 2.9 84.0 ± 2.3 67.5 ± 3.4 79.3 ± 2.7
   Role physical 32.8 ± 4.3 66.1 ± 4.6 35.2 ± 4.9 59.4 ± 5.3
   Role emotional 85.9 ± 3.7 93.6 ± 4.2 80.5 ± 4.3 85.9 ± 4.8
   Mental health 79.2 ± 1.7 87.0 ± 1.4 76.1 ± 2.0 84.1 ± 1.6
   Vitality 54.7 ± 2.2 66.0 ± 2.8 56.0 ± 2.6 65.8 ± 3.2
   Bodily pain 58.4 ± 3.3 81.9 ± 2.2 58.7 ± 3.9 83.6 ± 2.5
   General health 79.6 ± 1.6 79.7 ± 1.8 79.1 ± 1.8 76.8 ± 2.0
   Health change 44.4 ± 2.3 45.5 ± 2.2 48.2 ± 2.6 45.7 ± 2.5
   PCS 51.9 ± 2.3 76.9 ± 2.1 52.5 ± 2.7 75.1 ± 2.4
   MCS 71.3 ± 2.0 83.1 ± 2.0 69.8 ± 2.2 78.7 ± 2.3
   Total 59.8 ± 1.8 76.1 ± 1.7 59.6 ± 2.1 73.6 ± 2.0
CIS
   Subjective fatigue 35.3 ± 1.4 26.3 ± 1.3 34.6 ± 1.6 28.9 ± 1.5
   Reduced motivation 13.0 ± 0.7 8.7 ± 0.5 13.3 ± 0.8 9.8 ± 0.5
   Reduced activity 12.0 ± 0.6 8.4 ± 0.5 12.2 ± 0.7 9.0 ± 0.6
   Reduced concentration 14.8 ± 0.8 13.2 ± 0.9 15.4 ± 1.0 14.7 ± 1.0
   Total 74.8 ± 2.9 56.6 ± 2.5 74.8 ± 3.3 62.5 ± 2.9
Numbers are mean ± SEM
SF-36 = 36 item short-form health survey, PCS = Physical component summary, MCS = Mental component 
summary, CIS = Checklist individual strength.
a Repeated measures ANOVA, adjusted for baseline differences (mode of delivery and estimated blood loss)
Linear regression analysis showed no association of anemia and the amount of blood 
loss with any of the SF-36 and CIS scales at both time points. Mode of delivery was 
associated with scores on the SF-36 scales physical functioning (ß = -0.29; p < 0.0001), 
social functioning (ß = -0.19; p = 0.027), bodily pain (ß = -0.19; p = 0.023), and PCS (ß 
= -0.23; p = 0.007) on T0. On T5, mode of delivery was associated with scores on the 
SF-36 scales physical functioning (ß = -0.43; p < 0.0001), role physical (ß = -0.24; p = 
0.017), bodily pain (ß = -0.27; p = 0.008), and PCS (ß = -0.32; p = 0.002), and on the 
CIS scale reduced activity (ß = 0.31; p = 0.002). Women after cesarean section scored 
worse compared with women after a vaginal delivery. The explained variance (R2) of 
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these significant variables ranged from 4.7% (SF-36 social functioning T0) to 17.4% 
(SF-36 physical functioning on T5).
Discussion
This prospective cohort study assessing postpartum HS and fatigue found no 
differences among groups of women with and without postpartum anemia adjusting 
for baseline differences in mode of delivery and the amount of blood loss. HS and 
fatigue scores significantly improved over time in all women.
Cesarean section was significantly more common in women without than with 
postpartum anemia, a difference that may explain the significant differences in 
physical functioning and PCS scores between these two groups before adjustment, 
since cesarean section is known to affect physical HS [12]. The anemic group more 
frequently delivered vaginally, with increased of blood loss, than the non-anemic 
group. By contrast, a previous study found that blood loss was greater in women 
who underwent cesarean section than those who delivered vaginally, although 
postpartum Hb levels did not differ significantly [18].
To our knowledge, this is the first study to compare all domains of HS and fatigue 
(physical, mental, and social functioning) in postpartum women with and without 
anemia. In contrast to previous findings, we observed no association between anemia 
and fatigue conceptions [7]. In agreement with an earlier study, we found that HS and 
fatigue scores improved over time in all groups and were not associated with Hb level 
[12].
A limitation of the present study was the selection bias. Hb and iron status was 
only determined if indicated. Since all women who underwent a cesarean section 
were subjected to routine blood analysis, 54% of the enrolled women delivered by 
cesarean section. We therefore adjusted for mode of delivery in our analyses. Based 
on the time required for erythroblast maturation, we expected that improvements in 
Hb concentrations and any differences in HS and fatigue scores among the groups 
would have been observed after 5 weeks [19]. Others have shown, however, that the 
average periods required to reach full recovery on physical HS scales were 3 weeks 
after vaginal delivery, 6 weeks after elective cesarean section, and more than 6 
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weeks after emergency cesarean section [12]. We performed a subgroup analysis to 
determine the effect of elective and emergency cesarean section on HS and fatigue 
and found no differences in any of the HS and fatigue scores between the groups (data 
not shown). Another limitation of this paper is that there is no blood measurement 
before delivery, since prepartum anemia combined with acute bleeding anemia due 
to blood losses at delivery are the major causes of postpartum anemia [1]. In The 
Netherlands, blood examination is regularly performed during pregnancy, and not 
routinely when women are admitted to the hospital for delivery. In accordance with 
international guidelines, iron treatment is based on Hb measurement at 48 hours 
postpartum [1,3]. Since prepartum Hb was lacking, anemic postpartum women might 
have been anemic before delivery. It is known that chronically anemic women get 
used to decreased energy levels; this could explain why no differences were found in 
HS and fatigue scores between anemic and non-anemic postpartum women. Future 
research should examine the effect of acute and chronic anemia postpartum on HS 
and fatigue.
Most studies on postpartum anemia have focused on hematological outcomes after 
iron supplementation, with many showing that iron had a positive effect on maternal 
iron status [6]. Our results, however, suggest that iron supplementation may not be 
necessary in the treatment of postpartum anemia. Since HS and fatigue did not differ 
among the groups, iron supplementation may only worsen HS because of its known 
side effects. A prospective longitudinal study is needed to determine the relationships 
between severity of postpartum anemia and maternal morbidity, HS, and fatigue in 
women who do and do not receive iron supplementation.
In conclusion, postpartum women with anemia did not show a greater improvement 
in HS and fatigue when compared with non-anemic women during the first 5 weeks 
postpartum. All women showed significant improvements in HS and fatigue over 
time.
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Chapter 4
The high prevalence of vitamin D 
insuffi ciency in postpartum women 
is not related to infant feeding 
method, health status and fatigue.
D.A.A. van der Woude, D. van den Brand, J. de Vries, E.M. van Wijk, J.M.A. Pijnenborg
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Purpose: Vitamin D deficiency is a worldwide health problem that affects 
musculoskeletal health, acute and chronic diseases, and even fatigue. Inadequate 
vitamin D levels are highly prevalent in postpartum lactating women, who are 
advised to use vitamin D supplementation. The aim of this study was to assess the 
prevalence of insufficient vitamin D levels in postpartum women in relation to infant 
feeding method, and to compare health status (HS) and fatigue between vitamin D 
sufficient and insufficient postpartum women with regard to infant feeding method. 
Methods: This cross-sectional observational study included 113 Dutch postpartum 
women with persistent breast or bottle feeding at 5 weeks postpartum. Vitamin D 
sufficiency was defined according to international guidelines as 25-OH-vitamin D 
≥ 50 nmol/L. HS and fatigue were measured using the 36 item Short-Form Health 
Survey (SF-36), and the Checklist Individual Strength (CIS).
Results: Insufficient vitamin D levels were found in 57% of the breastfeeding 
women, and 64% of the bottle feeding women (p = 0.46). Scores on the mental 
health scale (SF-36) were significantly worse in vitamin D insufficient compared 
with sufficient breastfeeding women (p = 0.034). Among the bottle feeding groups, 
social functioning (SF-36) was significantly worse in the sufficient vitamin D group 
compared with the vitamin D insufficient group (p = 0.047). Linear regression analysis 
showed no association of infant feeding method with vitamin D concentration (ß 
= 0.00; p = 1.00). Summer (ß = 0.72; p < 0.0001) and fall (ß = 0.24; p = 0.011) were 
significantly associated with vitamin D concentration. Vitamin supplementation (ß 
= 0.27; p < 0.0001) and Caucasian ethnicity (ß = 0.18; p = 0.015) were also significantly 
associated with vitamin D concentration.
Conclusion: Postpartum vitamin D insufficiency was as frequent in lactating women 
as in women who bottle-fed their infant. HS and fatigue were not associated with 
insufficient vitamin D levels in postpartum women. In order to ensure good bone 
health, the international recommendation for supplementation of 10 – 15 micrograms 
vitamin D per day should include all postpartum women.
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Introduction
Vitamin D deficiency has been recognized to be a worldwide health problem that 
affects not only musculoskeletal health, but also a wide range of acute and chronic 
diseases such as type 1 diabetes mellitus, cardiovascular disease, certain cancers, 
cognitive decline, depression, pregnancy complications, autoimmunity, allergy, and 
even fatigue [1-4]. Impaired health status (HS) was also found to be associated with 
insufficient vitamin D levels in premenopausal women [5].
Vitamin D is a fat-soluble prohormone produced endogenously in the skin from sun 
exposure (66%) or obtained from food sources such as fatty fish, eggs, fortified milk, 
and cod liver oil or vitamin D supplements [1]. Vitamin D is hydroxylated in the liver 
to form the major circulating metabolite 25-hydroxyvitamin D (25-OH-vitamin D), 
which is used to determine a patient’s vitamin D status [1]. Vitamin D levels decrease 
significantly during late pregnancy and even more in the postpartum lactating period 
[6, 7]. Inadequate vitamin D levels were reported in 23% of Danish and 99.7% of 
Indian lactating women at six to eight weeks postpartum [6, 8]. Low maternal vitamin 
D levels during pregnancy were found to be associated with an increased risk of 
preeclampsia, gestational diabetes mellitus, preterm birth, small for gestational age, 
and antenatal and postpartum depression [9-13]. Therefore, international guidelines 
recommend supplementation of 10 – 15 micrograms (= 400 – 600 UI) vitamin D per day 
for pregnant and lactating women [14, 15]. No recommendation exists for postpartum 
women who bottle feed their infants.
To date, comparative research on vitamin D status between breastfeeding and 
bottle feeding postpartum women is lacking. Because vitamin D deficiency has a 
high prevalence in lactating women, it is important to know if fatigue and HS is 
diminished in this group of women. HS is a multidimensional concept that reflects 
physical, mental and social functioning and can be assessed by HS measures [16]. The 
aim of the present study was to assess the prevalence of insufficient vitamin D levels 
in postpartum women in relation to infant feeding method, and to compare HS and 
fatigue between vitamin D sufficient and insufficient postpartum women with regard 
to infant feeding method. Linear regression analyses were performed to make a more 
comprehensive assessment of the effect of infant feeding method, season, ethnicity, 
and vitamin supplementation on postpartum vitamin D concentration.




The present cross-sectional study was conducted between April 2008 and August 
2010 at the Department of Obstetrics and Gynecology, TweeSteden Hospital Tilburg, 
in the southern part of the Netherlands. Approval was obtained from the local ethic 
committee (file number NL21797.028.08). All women received verbal and written 
information about the study, and provided verbal and written informed consent. 
Women were eligible for inclusion if they were 18 years or older, thoroughly understood 
the Dutch language, and had indications for hemoglobin (Hb) determination within 
48 hours after delivery. Indications included estimated blood loss over 500 mL, delivery 
by cesarean section, manual removal of the placenta, and clinical symptoms of anemia. 
Women were excluded for the following reasons: Hb less than 6.4 g/dL (because the 
hospital protocol indicates the need for packed cell transfusion); addiction to alcohol 
or drugs; hematological disease; vitamin B12 deficiency (serum vitamin B12 < 100 
nmol/l and holotranscobalamin < 20 pmol/l). 
Maternal venous blood was collected and questionnaires assessing HS and fatigue 
were completed at the outpatient clinic at 5 weeks postpartum. Women were divided 
in two groups; those with persistent breastfeeding, and those with persistent bottle 
feeding during the first 5 weeks postpartum. Vitamin D sufficiency was defined 
according to international guidelines as 25-OH-vitamin D ≥ 50 nmol/L [6, 14, 17]. 
Venous blood samples were obtained in the non-fasting state. Serum was 
immediately separated and stored at – 80 °C. Serum 25-OH-vitamin D was measured 
by chemiluminescence immunoassay (CLIA) using a Liaison analyzer (Diasorin, 
Saluggia, Italy). The coefficient of variation of control material was 2.5 % (target value 
50.9 nmol/L). To convert values from nmol/L to μg/L, multiply by 0.400641; to convert 
values from μg/L to nmol/L, multiply by 2.496. 
HS was measured using the self-reported standardized 36-item Short-Form Health 
Survey (SF-36). The measure has eight scales (physical functioning, role physical, 
bodily pain, general health, vitality, social functioning, role emotional, and mental 
health) that form a physical component summary (PCS) and a mental component 
summary (MCS) [18]. The SF-36 has demonstrated good psychometric properties in 
postpartum women [19].
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Fatigue was measured using the Checklist Individual Strength (CIS), a 
multidimensional scale that quantifies subjective fatigue and related behavioral 
aspects [20]. The 20-items cover four dimensions: subjective experience of fatigue, 
reduced concentration, reduced motivation, and reduced physical activity level. The 
CIS has been shown reliable and valid in patients with chronic fatigue syndrome, as 
well as in healthy populations [21]. 
Statistical analysis
Statistical analyses were performed using SPSS 15.0. Continuous variables at 
baseline were compared by independent sample T-tests and nominal variables by 
Chi-square tests. Analyses of Covariance (ANCOVA) were used to compare HS and 
fatigue scores between sufficient and insufficient vitamin D level by infant feeding 
method. Potential baseline differences were entered as covariates. Linear regression 
analysis (method: enter) was performed to make a more comprehensive assessment 
of the effect of infant feeding method (breastfeeding or bottle feeding), season of 
inclusion (winter, spring, summer, and fall), ethnicity (Caucasian or not), and vitamin 
supplementation (yes or no) on postpartum vitamin D concentration. To assess the 
effect of season on vitamin D concentration, winter was chosen as reference group. All 
results are reported as mean ± standard deviation, mean (95% confidence interval), 
or number (percentage). A p-value of < 0.05 was considered statistically significant. 




A total of 113 women were included in this study; 58 women with persistent 
breastfeeding, and 55 women with persistent bottle feeding at 5 weeks postpartum. 
Insufficient vitamin D levels were found in 33 of the breastfeeding women, and 35 of 
the bottle feeding women (57% respectively 64%, p = 0.46) (Figure 1). 
Figure 1 Flow of participants through the study
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The demographic and clinical characteristics among the groups are shown in Table 1. 
There was a significant difference in age (p = 0.042) and distribution within included 
season (p < 0.0001) between the breastfeeding groups, and a significant difference 
in highest education (p = 0.006), vitamin use (p = 0.039), and distribution within 
included season (p = 0.01) between the bottle feeding groups. 
Table 1 Demographic and clinical characteristics a 
Characteristics
Breastfeeding Bottle feeding
Sufficient (n=25) Insufficient (n=33) Sufficient (n=20) Insufficient (n=35)
Age (years) b 31.2 ± 3.6 30.9 ± 5.2 30.2 ± 3.9 31.2 ± 4.4
BMI 25.1 ± 3.3 27.7 ± 5.8 26.6 ± 4.6 27.3 ± 5.4
Parity at baseline 1.5 ± 0.7 1.6 ± 0.9 1.5 ± 0.8 1.6 ± 0.7
Gestational age at 
delivery (weeks)
40.0 ± 1.4 39.7 ± 1.4 40.1 ± 1.3 39.7 ± 1.6
Caucasian ethnicity 23 (92) 24 (73) 20 (100) 32 (91.4)
Highest education c
   Lower 1 (4) 1 (3) 0 (0) 2 (6)
   Medium 9 (36) 15 (47) 17 (85) 13 (41)
   High 15 (60) 16 (50) 3 (15) 17 (53)
Vitamin use d 
   No 8 (32) 16 (50) 10 (50) 27 (77)
   Multivitamins or vitamin D 17 (68) 16 (50) 10 (50) 8 (23)
Delivery method
   Vaginal 9 (36) 17 (51.5) 12 (60) 14 (40)
   Cesarean 16 (64) 16 (48.5) 8 (40) 21 (60)
Season e,f
   Spring 1 (4.0) 10 (30.3) 6 (30.0) 14 (40.0)
   Summer 18 (72.0) 6 (18.2) 10 (50.0) 4 (11.4)
   Autumn 6 (24.0) 9 (27.3) 2 (10.0) 4 (11.4)
   Winter 0 (0.0) 8 (24.2) 2 (10.0) 13 (37.2)
Hemoglobin (g/dL) 12.9 ± 0.7 12.6 ± 0.9 12.6 ± 0.9 12.1 ± 1.2
Sleeping hours per night 
last week
6.3 ± 0.9 6.1 ± 1.3 6.2 ± 1.1 6.0 ± 1.7 
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by the square of height in 
meters). 
a Values are given as mean ± SD or number (percentage)
b Independent T-test p = 0.042 between insufficient en sufficient groups of breastfeeding women
c Chi-square p = 0.006 between insufficient and sufficient groups of bottle feeding women
d Chi-square p = 0.039 between insufficient and sufficient groups of bottle feeding women
e Chi-square p < 0.0001 between insufficient and sufficient groups of breastfeeding women
f Chi-square p = 0.010 between insufficient and sufficient groups of bottle feeding women
Note: There were no significant differences between the other variables.
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There were no significant differences on the HS and fatigue scales between the 
women with and without sufficient vitamin D levels in the breastfeeding women 
(Table 2). Among the bottle feeding groups, general health (SF-36) was significantly 
worse in the insufficient vitamin D group (p = 0.035, Table 3). Other HS and fatigue 
scores were not different between the bottle feeding groups.
Table 2 Health status and fatigue between sufficient and insufficient vitamin D levels in breastfeeding women a
Breastfeeding
Sufficient vitamin D (n=25) Insufficient vitamin D (n=33)
SF-36
   Physical functioning 77.3 (67.9 – 86.8) 77.4 (71.3 – 83.5)
   Social functioning 85.3 (74.2 – 96.5) 74.9 (67.8 – 82.0)
   Role physical 58.7 (34.6 – 82.8) 51.1 (35.3 – 66.8)
   Role emotional 93.9 (76.9 – 110.8) 80.4 (69.4 – 91.5)
   Mental health 89.0 (83.2 – 94.9) 83.9 (80.1 – 87.6)
   Vitality 60.5 (52.7 – 68.4) 65.7 (60.7 – 70.8)
   Bodily pain 86.9 (77.0 – 96.8) 77.9 (71.5 – 84.2)
   General health 82.0 (76.0 – 88.0) 78.9 (75.0 – 82.7)
   Health change 49.1 (39.0 – 59.2) 46.5 (40.0 – 53.0)
   Physical component summary 75.2 (65.3 – 85.1) 71.5 (65.1 – 77.9)
   Mental component summary 82.1 (73.7 – 90.5) 76.6 (71.1 – 82.1)
   Total 75.2 (67.3 – 83.1) 71.0 (65.9 – 76.1)
CIS
   Subjective fatigue 27.1 (21.4 – 32.9) 28.7 (25.0 – 32.4)
   Reduced motivation 9.6   (7.3 – 12.0) 10.4 (8.9 – 11.9)
   Reduced activity 10.8 (8.4 – 13.2) 10.0 (8.5 – 11.5)
   Reduced concentration 16.5 (12.5 – 20.5) 15.0 (12.5 – 17.6)
   Total 64.6 (53.4 – 75.7) 64.0 (56.9 – 71.1)
Abbreviations: SF-36, 36-item Short Form health survey, and CIS, Checklist individual strength. 
a Values are given as mean (95% CI), corrected for baseline differences (age, season).
Analyses of covariance (ANCOVA): There were no significant differences between the sufficient vitamin D and 
insufficient vitamin D group on the variables.
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Table 3 Health status and fatigue between sufficient and insufficient vitamin D levels in bottle feeding women a
Bottle feeding
Sufficient vitamin D (n=20) Insufficient vitamin D (n=35)
SF-36
   Physical functioning 88.0 (74.0 – 101.9) 85.3 (74.6 – 96.0)
   Social functioning 80.6 (67.0 – 94.2) 93.7 (83.2 – 104.2)
   Role physical 74.5 (48.0 – 101.1) 84.8 (64.4 – 105.3)
   Role emotional 88.6 (70.8 – 106.4) 97.0 (83.3 – 110.7)
   Mental health 84.2 (73.8 – 94.5) 86.5 (78.5 – 94.5)
   Vitality 72.8 (60.8 – 84.7) 68.4 (59.2 – 77.6)
   Bodily pain 88.4 (73.2 – 103.7) 85.9 (74.1 – 97.6)
   General health b 84.8 (70.9 – 98.7) 70.0 (59.3 – 80.7)
   Health change 51.2 (37.3 – 65.1) 48.7 (38.0 – 59.4)
   Physical component summary 83.9 (69.5 – 98.4) 81.5 (70.4 – 92.6)
   Mental component summary 81.5 (70.4 – 92.7) 86.4 (77.8 – 95.0)
   Total 79.2 (69.0 – 89.5) 80.0 (72.1 – 87.9)
CIS
   Subjective fatigue 23.9 (14.9 – 32.8) 25.1 (18.3 – 32.0)
   Reduced motivation 7.8   (4.6 – 11.0) 8.0   (5.6 – 10.5)
   Reduced activity 5.8   (2.5 – 9.1) 6.9   (4.4 – 9.4)
   Reduced concentration 14.5 (8.2 – 20.8) 12.9 (8.1 – 17.7)
   Total 52.3 (34.0 – 70.5) 53.4 (39.4 – 67.3)
Abbreviations: SF-36, 36-item Short Form health survey, and CIS, Checklist individual strength.
a Values are given as mean (95% CI), corrected for baseline differences (highest education, season, vitamin use).
b Analyses of Covariance (ANCOVA) p = 0.035.
Note: There were no significant differences between the sufficient vitamin D and insufficient vitamin D group 
on the other variables.
Linear regression analysis showed no association of infant feeding method with 
vitamin D concentration (ß = 0.00; p = 1.00). Regarding season, summer (ß = 0.72; 
p < 0.0001) and fall (ß = 0.24; p = 0.011) were significantly associated with vitamin 
D concentration. Vitamin supplementation (ß = 0.27; p < 0.0001) and Caucasian 
ethnicity (ß = 0.18; p = 0.015) were also significantly associated with vitamin D 
concentration. The explained variance (R2) was 47%.
Discussion 
The current study shows that more than half of the women had insufficient vitamin 
D levels at 5 weeks postpartum, with no difference between the breastfeeding 
and bottle feeding women. Vitamin D concentration in postpartum women was 
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associated with season of inclusion, vitamin supplementation, and ethnicity. Scores 
on the SF-36 general health scale were significant worse in the bottle feeding women 
with insufficient vitamin D levels. 
To our knowledge, this is the first study that reports the prevalence of postpartum vitamin 
D insufficiency in both lactating women as in women who bottle-feed their infant. It is 
also the first study reporting complete HS (physical, mental, and social functioning) and 
fatigue comparing vitamin D insufficient and sufficient postpartum women. 
Several limitations need to be addressed. Women were only included in the present 
study if an indication for Hb determination existed. Hb level was not different 
between the study groups and seems therefore not associated with vitamin D status. 
Also, we performed linear regression analyses and found no association of Hb level, 
amount of blood loss, mode of delivery, manual removal of the placenta, and clinical 
symptoms of anemia with vitamin D concentration (data not shown). 
No clear definition exists for vitamin D insufficiency, but most agree that a 25-OH 
vitamin D serum level of at least 50 nmol/L is needed to avoid bone problems [1, 14]. 
Therefore, we also used this cut-off value. Due to the small sample size we did not 
examine vitamin D deficiency, insufficiency, and sufficiency with regard to infant 
feeding method. Vitamin D deficiency (25-OH-vitamin D < 25 nmol/L) was present in 
6 women in the breastfeeding group and 9 in the bottle feeding group (10.3% versus 
16.4%, p = 0.35). There were no differences in HS and fatigue when comparing vitamin 
D deficient, insufficient and sufficient postpartum women (data not shown). 
Dietary intake of vitamin D containing products was not addressed in this study. 
However, the major source of vitamin D is sunlight, and a recent review showed that 
vitamin D intake is consistently below nutrient recommendation levels in pregnant 
women in developed countries [1, 22]. 
Vitamin D insufficiency (< 50 nmol/L) is a worldwide problem with a prevalence 
ranging from 23% of Danish and 99.7% of Indian breastfeeding women [6, 7]. 
The present study found insufficient vitamin D levels in 57% of the breastfeeding 
women. The difference in prevalence may be caused by differences in diet, vitamin 
supplementation use, sun exposure, and skin color [23-25]. 
The statistical significant difference on the SF-36 general health scale between the 
bottle feeding groups is more likely to reflect multiple testing or chance, than a 
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difference with clinical meaning since general health was not different between the 
breastfeeding groups. 
In contrast to a previous study in premenopausal women with inadequate vitamin 
D levels, we observed no association between inadequate vitamin D levels and HS in 
postpartum women [5]. Also, fatigue scores were not different between the vitamin 
D sufficient and insufficient groups, which is in contrast with previous studies that 
associated fatigue with inadequate vitamin D levels in general practice [2-4]. In 
present study, a higher vitamin D concentration was associated with summer and fall, 
vitamin supplementation, and ethnicity (being Caucasian), which corresponds with 
the literature [23-25].
International guidelines recommend vitamin D supplementation for pregnant 
and lactating women [14, 15, 25]. If an indication for vitamin D supplementation 
includes high frequency of inadequate vitamin D levels to maintain bone health, all 
postpartum women should be supplemented instead of only the lactating women. 
The present study was conducted in the Netherlands, most women were Caucasian, 
and indication for inclusion were Hb determination; therefore these results cannot be 
extrapolated to all postpartum women and to not Western countries. Future research 
should focus on HS, fatigue, and co-morbidity after vitamin D supplementation 
during the postpartum period.
Conclusion
More than half of the postpartum had insufficient vitamin D levels, which was as 
frequent in lactating women as in women who bottle-fed their infant. A higher 
vitamin D concentration was associated with season of inclusion (summer or fall), 
vitamin supplementation, and ethnicity (being Caucasian), but not with HS and 
fatigue. In order to ensure good bone health, the international recommendation 
for supplementation of 10 – 15 micrograms vitamin D per day should also include 
postpartum women who bottle feed their infants. 
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Chapter 5
Vitamin B12 in postpartum women: 
a prospective cohort study
D.A.A. van der Woude, J.M.A. Pijnenborg, J. de Vries, E.M. van Wijk
Submitted




Objective: To assess the prevalence of vitamin B12 deficiency in the first five weeks 
postpartum, and to examine the fraction of active vitamin B12.
Design: A prospective cohort study.
Setting: Large teaching hospital in Tilburg, the Netherlands.
Population: 171 postpartum women.
Methods: Total vitamin B12 and holotranscobalamin (holoTC) were measured within 
48 hours (T0) and at 5 weeks (T5) postpartum. Vitamin B12 deficiency was defined as 
total vitamin B12 < 180 pmol/L or holoTC < 32 pmol/L. The fraction of active vitamin 
B12 was defined as holoTC/total vitamin B12.
Main outcome measures: Vitamin B12 deficiency at T0 and T5 based on total vitamin 
B12 and holoTC, and the fraction of active vitamin B12 in vitamin B12 deficient women.
Results: Without intervention, vitamin B12 deficiency based on both serum vitamin 
B12 and holoTC changed from 75% and 60% at T0, to respectively 10% and 6% at T5. 
Total vitamin B12 deficient women had a significant higher fraction of active vitamin 
B12 compared with not deficient women at both T0 (p < 0.0001, mean 0.25 ± SD 0.12 
and mean 0.19  ± SD 0.07) and T5 (p < 0.0001, mean 0.28  ± SD 0.08 and mean 0.21  ± 
SD 0.06). The vitamin B12 deficiency group had a higher fraction of active vitamin B12 
compared with the not vitamin B12 deficiency group (p = 0.002).
Conclusions: The results suggest physiological changes of vitamin B12 postpartum with 
a shift towards the metabolic active vitamin B12 (holoTC) in women with insufficient 
available total vitamin B12. Postpartum women without risk factors or manifestations 
of a true vitamin B12 deficiency do not need vitamin B12 supplementation. 
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Introduction
Serum vitamin B12 (cobalamin) concentrations show a significant decrease in each 
trimester during pregnancy to marginal or non-pregnant deficient values in healthy 
pregnant women [1-4]. Postpartum, vitamin B12 concentrations spontaneously 
recover to preconceptional values [1, 5]. However, serum vitamin B12 measurement 
has a low positive predictive value, meaning that a low serum vitamin B12 level 
not always indicates an actual vitamin B12 deficiency at tissue level [6]. Therefore, 
supplementation of vitamin B12 in the absence of manifestations of deficiency is a 
matter of debate in the current literature [6, 7].
Several studies conclude that the observed change of serum vitamin B12 during 
pregnancy and postpartum is physiologic [1, 2]. Despite depressed vitamin B12 
concentrations, homocysteine and methylmalonic acid levels were not elevated as 
would be expected in vitamin B12 deficiency [1-3, 5, 8]. Also, a concomitant increase 
in erythrocyte cobalamin was observed [2]. Explanations for the cobalamin reduction 
are hemodilution, transportation to the fetus, and redistribution of cobalamin. 
However, serum vitamin B12 concentrations during pregnancy decline more than can 
be accounted for by hemodilution [8]. Also, the total requirement of the fetus during 
pregnancy is estimated to be 50 μg, while maternal stores in women with mixed diet 
are estimated at > 1000 μg [9]. Therefore, in well-nourished women, body stores of 
vitamin B12 are adequate to meet fetal needs during gestation [10]. The combination 
of a decrease in total serum vitamin B12, the increase in erythrocyte cobalamin, and a 
decrease in saturation of cobalamin binding serum proteins suggests a redistribution 
of cobalamin [2].
Only 20% of serum vitamin B12 is bound to transcobalamin (holoTC), which is the 
active part of vitamin B12 available for tissue uptake [11]. The remaining 80% is bound 
to haptocorrin (holohaptocorrin, holoHC) and has no known biological function 
[12]. Several studies showed that HoloTC remains constant during pregnancy and 
postpartum [1, 5], while holoHC decreases during pregnancy [2]. Our hypothesis is that 
a shift occurs towards holoTC in women with insufficient available total vitamin B12. 
Therefore, the fraction of active vitamin B12 (holoTC/total vitamin B12) will be higher 
in women with vitamin B12 deficiency. Our objectives were to examine the prevalence 
of vitamin B12 deficiency based on total vitamin B12 and holoTC directly and at five 
weeks postpartum, and to compare the fraction of active vitamin B12 between vitamin 
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B12 deficient and not deficient women during the first weeks postpartum. We also 
examined the effect of postpartum multivitamin use on vitamin B12 deficiency and 
fraction of active vitamin B12 at 5 weeks postpartum.
Materials and methods
Study design and population
The current prospective study was performed between April 2008 and August 2010 at 
a large teaching hospital in Tilburg, in the southern part of the Netherlands. The study 
was approved by the local ethics committee (file number NL21797.028.08). All women 
received oral and written information about the study and provided oral and written 
informed consent. Women were eligible for inclusion if they were ≥ 18 years old, 
thoroughly understood the Dutch language, and had indications for blood sampling 
within 48 hours after delivery, including estimated blood loss > 500 ml, delivery by 
cesarean section, manual removal of the placenta, and clinical symptoms of anemia. 
Women were excluded if: their hemoglobin was < 6.4 g/dL (because the hospital 
protocol indicates the need for packed red cell transfusion); they were addicted to 
alcohol or drugs; they had hematological disease; they had chronic inflammatory 
disease; or they were being treated with methotrexate.  
Procedure
Maternal venous blood was collected in the hospital within 48 hours after delivery 
(T0) and at five weeks postpartum (T5) in the outpatient clinic. The women were 
not informed of their vitamin B12 levels. None of the women received vitamin B12 
supplementation. If they used multivitamins, they were allowed to continue them.
Total vitamin B12 was measured on an Advia Centaur immunoassay system (Siemens 
Healthcare Diagnostics, Breda, The Netherlands). HoloTC was measured in each serum 
sample using an AxSYM immunoassay analyzer (Abbott Diagnostics, Hoofddorp, 
The Netherlands). These parameters were measured in control and analyzed in the 
normal diagnostic practice of the laboratory. In our hands, the respective between-
run coefficients of variation for vitamin B12 and holoTC were 3.1 % (at a vitamin B12 
level of 180 pmol/L) and 4.3 % (at a holoTC level of 30 pmol/L).
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Outcomes
Vitamin B 12 deficiency was defined as total vitamin B12 < 180 pmol/L or holoTC < 32 
pmol/L [13]. The fraction of active vitamin B12 was defined as holoTC/total vitamin B12 
[14].
Statistical analyses
Statistical analyses were performed using SPSS 20.0. Continuous variables at baseline 
were compared by independent sample T-tests and nominal variables by Chi-square 
tests. The McNemar test was used to determine the distribution of vitamin B12 and 
holoTC deficiency from T0 to T5. The independent sample T-test was used to determine 
the difference in fraction of active vitamin B12 between the vitamin B12 deficient 
and not deficient women at T0 and T5. Analysis of variance for repeated measures 
was used to compare the mean fraction of active vitamin B12 between vitamin B12 
deficient and not deficient women. The effect of postpartum multivitamin use on 
vitamin B12 deficiency and fraction of active vitamin B12 at T5 was assessed using 
Chi-square and independent T-test. All results were reported as the mean ± standard 
deviation (SD), or percentage (%), as appropriate.




A total of 171 women were included in the study. The demographic and clinical 
characteristics of the participants at baseline are shown in Table 1. 
Table 1 Patient demographic and clinical characteristics at baseline (T0)
Vitamin B12 < 180 pmol/L 
(n=129)
Vitamin B12 ≥ 180 pmol/L
(n=42)
Age at entry (years) 30.5 ± 4.6 31.3 ± 3.8
BMI before pregnancy (kg/m2) 25.7 ± 5.8 24.8 ± 4.9
Twin pregnancies 2 (1.6) 1 (2.4)
Ethnicity
   Caucasian 117 (90.7) 39 (92.9)
   Turkish 4 (3.1) 0 (0.0)
   African 4 (3.1) 1 (2.4)
   Asian 2 (1.6) 1 (2.4)
   South American 2 (1.6) 1 (2.4)
Smoking 13 (10.1) 3 (7.1)
Diet
   Omnivore 78 (60.5) 27 (64.3)
   Vegetarian 4 (3.1) 0 (0.0)
   Unknown 47 (36.4) 15 (35.7)
Multivitamin use 1 43/101 (42.6) 21/36 (58.3)
Parity at baseline 1.5 ± 0.7 1.3 ± 0.6
Gestational age at delivery (weeks) 39.9 ± 1.5 39.5 ± 1.5
Delivery method 
   Vaginal 53 (41.4) 13 (31.0)
   Cesarean section 76 (58.6) 29 (69.0)
Infant birth weight (gram) 3510.5 ± 553.5 3435.1 ±  493.2
Infant feeding:
   Breastfeeding 78 (60.5) 26 (61.9)
   Bottle (formula) feeding 51 (39.5) 16 (38.1)
Holotranscobalamin a
   < 32 pmol/L 86 (66.7) 16 (38.1)
   ≥ 32 pmol/L 43 (33.3) 26 (61.9)
Numbers are mean ± SD or number (percentage)
1 Unknown multivitamin use, n=34
a Chi square: p = 0.001
Note: There were no significant differences between the vitamin B12 deficient and not deficient group on the 
other variables.
33558 Woude, Daisy CS6.indd   72 27-04-15   16:18
5
Vitamin B12 in postpartum women
73
Vitamin B12 deficiency
HoloTC deficiency was significant more prevalent in women with total vitamin B12 
deficiency, and normal holoTC values were more prevalent in women with normal 
total vitamin B12 values (p = 0.001, Table 1).
Table 2 shows the significant differences in distribution of total vitamin B12 deficiency 
and holoTC deficiency from T0 to T5 (p < 0.0001). Vitamin B12 deficiency within 48 
hours postpartum was prevalent in 75% of the women based on total vitamin B12 
values, and in 60% of the women based on holoTC. At T5, vitamin B12 deficiency was 
prevalent in 9.9% based on total vitamin B12 values, and 5.8% based on holoTC. Of the 
129 vitamin B12 deficient women at T0, only 17 (9.9%) remained deficient at T5. Ten 
(5.8%) of the 102 holoTC deficient women at T0 remained deficient at T5. All women 
with normal vitamin B12 (n = 42, 24.6%) and holoTC values (n = 69, 40.4%) on T0, 
continued to have normal values on T5.
Table 2 Distribution of vitamin B12 and holotranscobalamin (holoTC) deficiency within 48 hours postpartum 
(T0) and at 5 weeks postpartum (T5)
Vitamin B12 T5
< 180 pmol/L ≥ 180 pmol/L Total
Vitamin B12 T0 < 180 pmol/L 17 (9.9) 112 (65.5) 129 (75.4)
≥ 180 pmol/L 0   (0.0) 42   (24.6) 42   (24.6)
Total 17 (9.9) 154 (90.1) 171 (100.0)
Numbers (percentage)
McNemar test: p < 0.0001
HoloTC T5
< 32 pmol/L ≥ 32 pmol/L Total
HoloTC T0 < 32 pmol/L 10 (5.8) 92   (53.8) 102 (59.6)
≥ 32 pmol/L 0   (0.0) 69   (40.4) 69   (40.4)
Total 10 (5.8) 161 (94.2) 171 (100.0)
Numbers (percentage)
McNemar test: p < 0.0001
Fraction of active vitamin B12
Total vitamin B12 deficient women had a significant higher fraction of active vitamin 
B12 compared with not deficient women at both T0 (p < 0.0001, mean 0.25 ± SD 0.12 
and mean 0.19  ± SD 0.07) and T5 (p < 0.0001, mean 0.28  ± SD 0.08 and mean 0.21  ± 
SD 0.06). A high fraction of active vitamin B 12 (> 0.40) was only present in women 
with total vitamin B12 deficiency at T0 (n = 13, Figure 1a). Of these, 85% (n = 11) had a 
normal holoTC level. At T5, no high vitamin B12 fraction was found (Figure 1b).
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Figure 1a Fraction of active vitamin B12 and holotranscobalamin (holoTC) between vitamin B12 deficient and not 
deficient women within 48 hours postpartum (T0)
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Figure 1b Fraction of active vitamin B12 and holotranscobalamin (holoTC) between vitamin B12 deficient and not 
deficient women at 5 weeks postpartum (T5)
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Repeated measures ANOVA showed that there was no interaction effect of fraction of 
active vitamin B12 and vitamin B12 deficiency (based on total vitamin B12, p = 0.054). 
Also, there was no effect of time with regard to active vitamin B12 fraction (p = 0.11). 
However, a significant group effect for the fraction of active vitamin B12 was observed 
(p = 0.002). The vitamin B12 deficiency group had a higher fraction of active vitamin 
B12 compared with the not vitamin B12 deficiency group.
Multivitamin use
At T5, multivitamin use of the included women was known in 137 of the 171 women; 52 
women (38%) used multivitamins, and 85 women did not use multivitamins (62%). 
There were no significant differences in vitamin B12 deficiency between the groups 
who did and did not use multivitamins at T5, based on both vitamin B12 (p = 0.45) 
and holoTC (p = 0.13). Also, no significant difference in fraction of active vitamin B12 
was found between the groups who did and did not use multivitamins at T5 (p = 0.58).
Discussion
Main findings
Without intervention, vitamin B12 deficiency based on both serum vitamin B12 
and holoTC changed from 75% and 60% at T0, to respectively 10% and 6% at T5. 
All women with normal serum vitamin B12 and holoTC values within 48 hours 
postpartum continued to have normal values at 5 weeks postpartum. The fraction 
of active vitamin B12 was significant higher in vitamin B12 deficient women at both 
time points and across time. A high fraction of active vitamin B 12 was only present 
in women with total vitamin B12 deficiency at T0. At T5, no high vitamin B12 fraction 
was found.
Strengths and weaknesses
The present study is limited by selection bias. All included women had indication 
for blood sampling based on potential anemia. However, earlier studies found 
no association of hemoglobin level and vitamin B12 status during pregnancy and 
postpartum [1, 2]. Homocysteine and methylmalonic acid levels were not measured 
to define vitamin B12 deficiency in the present study. However, earlier studies found 
no significant correlation between homocysteine or methylmalonic acid and vitamin 
B12 deficiency, both during pregnancy and postpartum [1, 5]. Another limitation of 
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the study is that in 36% of the included women the diet is unknown. Women who are 
vegetarian or vegan are at increased risk of vitamin B12 deficiency [6]. Yet, we believe 
that this has not affected our results. The four included vegetarian women in the 
present study were vitamin B12 deficient within 48 hours postpartum. Without the 
use of multivitamins, they all reached normal holoTC values at five weeks postpartum 
(data not shown).
Interpretation
The results of the present study show that the fraction of active vitamin B12 is 
higher in postpartum women with insufficient available serum vitamin B12, which 
suggests a shift towards the metabolic active vitamin B12 (holoTC). The spontaneous 
disappearance of vitamin B12 deficiency from directly postpartum to 5 weeks 
postpartum probably reflects physiological changes during the postpartum period 
rather than a true vitamin B12 deficiency. Earlier studies confirm these physiological 
changes. Despite depressed vitamin B12 concentrations, no elevation of homocysteine 
and methylmalonic acid levels were found, and an increase in erythrocyte cobalamin 
was found [1, 2].
To our knowledge, this is the first study reporting the course of serum vitamin B12, 
holoTC and fraction of active vitamin B12 in the first weeks postpartum. Based on 
serum vitamin B12, the prevalence of vitamin B12 deficiency in the present study was 
higher within 48 hours postpartum compared with the third trimester of pregnancy 
in the current literature (75% versus 35 to 43%) [1, 2]. Therefore, it seems that total 
vitamin B12 levels even decrease from the third trimester of pregnancy to immediately 
postpartum. The prevalence of vitamin B12 deficiency at 5 weeks postpartum in the 
present study is considerably higher compared with the prevalence as reported in 
a previous study on vitamin B12 deficiency at 8 weeks postpartum (10% versus 3%) 
[1]. This could be explained by the difference in time of measurement postpartum. 
It is expected that the serum vitamin B12 can spontaneously improve from 5 weeks 
to 8 weeks postpartum. The present study showed a significant increase of mean 
holoTC from T0 to T5 (p < 0.0001, mean 33.3 SD ±17.5 to 60.6 SD ± 24.0), which does 
not correspond to earlier studies which found that holoTC remains constant during 
pregnancy and postpartum [1, 5]. However, these studies measured holoTC at the third 
trimester of pregnancy and at 8 weeks postpartum, and not immediately postpartum. 
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Conclusion
The results of the present study suggest physiological changes of vitamin B12 
postpartum with a shift towards the metabolic active vitamin B12 (holoTC) in women 
with insufficient available total vitamin B12.
Because this study included women of different ages and parity, the results are 
applicable in daily medical practice. Supplementation of vitamin B12 in postpartum 
women can result in overtreatment. Therefore, postpartum women without risk 
factors or manifestations of a true vitamin B12 deficiency do not need vitamin B12 
supplementation. The present study was conducted in the Netherlands, and most 
women were Caucasian with western dietary habits Therefore, these results cannot 
be extrapolated to countries with a high prevalence of vegetarian diets. 
Future research should focus on postpartum vitamin B12 deficiency in women with 
different diet and ethnic backgrounds. 
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Chapter 6
An added value for the hemoglobin 
content in reticulocytes (CHr) and 
the mean corpuscular volume (MCV) 
in the diagnosis of iron defi ciency 
in postpartum anemic women
C. Ramakers, D.A.A. van der Woude, J.M. Verzijl, J.M.A. Pijnenborg, E.M. van Wijk
International Journal of Laboratory Hematology 2012; 34(5): 510-516 (Adapted version)




Introduction: To evaluate the use of reticulocyte hemoglobin content (CHr) and mean 
corpuscular volume (MCV) to identify truly iron deficient women with postpartum 
anemia (PPA), in order to reduce unnecessary iron supplementation.
Methods: Three hundred women with more than 500 mL of blood loss or clinical signs 
of anemia were divided in a control (hemoglobin [Hb] ≥ 10.5 g/dL, n = 150) and PPA 
group (Hb < 10.5 g/dL; n = 150). PPA women were given ferrous fumarate for a period 
of 4 weeks. Efficacy of the treatment was evaluated by comparing Hb, CHr, and MCV 
at baseline (T0) and after 4 weeks (T4). Using standard iron deficiency cut off values 
for MCV (80 fL) and CHr (28 pg) at T0, we divided the PPA group of both parameters 
into two subgroups, one suggestive for iron deficiency and one suggestive for non-
iron deficiency.
Results: Irrespective of the parameter or the subdivision, delta Hb concentrations 
(T4–T0) showed a similar increase in all PPA subgroups investigated. Both parameters 
in the PPA subgroups below their respective cut off value showed a significant 
improvement towards normalization, while the MCV and CHr in the PPA subgroups 
above their respective cut off value did not show any significant increase.
Conclusion: Our data suggest that the etiology of the anemia in postpartum anemic 
women is not always iron deficiency. Using a combination of Hb, MCV and CHr, we 
increased the stringency to identify truly iron-deficient postpartum anemic women, 
thereby reducing unnecessary iron supplementation in those women with sufficient 
iron stores.
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Introduction
Postpartum anemia (PPA) occurs frequently and is an important risk factor for maternal 
morbidity [1–3]. The prevalence of PPA varies considerably in the different studies, 
ranging from 22% to 27% [4, 5], with the highest prevalence in women with a low 
socioeconomic status [5]. Anemia in non-pregnant women is defined by the World 
Health Organization as a hemoglobin (Hb) concentration of < 12 g/dL (7.5 mM x 1.611) 
[6]. Although there is no clear cut off value for PPA in literature, the Dutch Society of 
Obstetrics and Gynecology-guideline for anemia uses a cut off value of 10.5 g/dL [7]. The 
difference in cut off value between non-pregnant and pregnant women is explained 
by the attempt to correct for the physiological hemodilution as present in pregnancy 
[8] and, more importantly, because of blood loss during labor. Because of this, added to 
the increased demand for iron during pregnancy, it is assumed that the most probable 
cause of anemia in the postpartum period is because of iron deficiency. While in our 
hospital, severe PPA (Hb < 6.5 g/dL) is treated with transfusion of packed red blood cells, 
treatment of mild PPA (6.5 ≤ Hb < 10.5 g/dL) consists of oral iron supplementation.
Ferrous fumarate is the most commonly used iron compound in Dutch obstetric 
practice. While severe side effects of iron supplementation (i.e., iron overload) are 
restricted to rare entities such as thalassemia or hemochromatosis (either congenital 
or acquired), most side effects are mild but nevertheless inconvenient, resulting in 
gastro-intestinal complaints such as nausea, diarrhea, or constipation [9].
Most anemia protocols make use of multiple laboratory parameters to unravel the 
etiology of the anemia at hand. However, in dealing with mild PPA, it is assumed that 
the most probable cause of the anemia is iron deficiency and consequently is treated 
as such. This assumption disregards the fact that some PPA women with sufficient 
iron stores have no beneficial effect of supplementation.
The reticulocyte hemoglobin content (CHr) is a relatively new measure for iron 
deficiency. Using the Prussian blue staining of a bone marrow aspirate to define 
iron deficiency, CHr outperformed the traditional markers like ferritin, transferrin 
saturation, and mean corpuscular volume (MCV) for the diagnosis of iron deficiency 
[10]. CHr is a parameter that can be measured on an Advia platform (Siemens 
Healhcare Diagnostics, Breda, Netherlands). However, comparable measurements of 
the reticulocyte hemoglobin content are available on other platforms [11, 12].
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In this study, we investigate the use of the CHr together with the MCV to establish 
whether or not iron deficiency is the true cause of the PPA, thereby preventing 
unnecessary supplementation and as a consequence averting potential side effects of 
iron supplementation in non-iron deficient women. Ferritin is also a well-established 
parameter for diagnosing iron deficiency anemia. However, in concurrence with the 
literature, we decided against using ferritin as a marker for iron deficiency in PPA women 
because of its prominent role in the acute phase response during parturition [13, 14].
Methods
Population
The source population consisted of women who delivered in the TweeSteden 
hospital in the period between January 2007 and December 2008. Table 1 shows an 
overview of all inclusion and exclusion criteria. Women aged 18 years or older, with 
more than 500 mL of blood loss during labor or with clinical signs of anemia (e.g., 
fatigue, loss of stamina, headache, faintness, pale skin, pale mucous membranes, 
hypotension, or tachycardia) were asked to join the study. After obtaining informed 
consent, all included women undergone blood testing (see below). Based on their Hb 
concentration, subjects were divided in a non-anemic control group (Hb ≥ 10.5 g/dL; n 
= 150) and a PPA index group (6.5 ≤ Hb < 10.5 g/dL; n = 150). Women with extreme PPA 
(Hb < 6.5 g/dL) were excluded because of packed red blood cells transfusion. The non-
anemic control group did not receive any prescribed medication. The PPA index group 
received ferrous fumarate (200 mg x 3 tablets a day) for a period of 4 weeks.
Table 1 Overview of all inclusion and exclusion criteria
Inclusion Exclusion
Women aged > 18 years
Thorough grasp of Dutch language
Informed consent acceptance
Delivery in a clinical obstetric setting
0 – 48 h after delivery
> 500 mL blood loss or clinical signs of anemia
Vitamin B12 deficiency (< 160 pm)










Methothrexate use (interaction with folic acid)
Contra-indications folic acid use
Contra-indications ferrous fumarate use
Criteria were checked during a thorough interview
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Laboratory parameters
Both the non-anemic control and the PPA index group were subjected to blood testing 
at the time of inclusion (T = 0 weeks, T0, being 0–48 hours after delivery) and during 
follow-up (T = 4 weeks, T4). The following parameters were tested: Hb, MCV, and CHr. 
These red blood cell parameters were measured in K2EDTA anti-coagulated blood on 
an ADVIA2120i or ADVIA120 Hematology platform (Siemens Healthcare Diagnostics 
Breda, The Netherlands). All parameters were measured in control and analyzed in 
the normal diagnostic practice of our laboratory. For the MCV and CHr, the respective 
coefficients of variation of control material were 1.55 (target value 85 fL) and 1.00% 
(target value 23 pg).
Cut of f values for MCV and CHr for iron deficiency
The MCV is a widely accepted erythrocyte index and is one of the first parameters 
to be analyzed in most anemia protocols. With the prerequisite that the Hb 
concentration is below the reference interval, an MCV of below 80 fL is indicative for 
iron deficiency [15]. Note that severe microcytosis (i.e., < 72 fL) is more suggestive for 
hemoglobinopathies [16].
The CHr is the product of the cellular volume and the Hb concentration of reticulocytes 
[17]. Compared to the slow turnover of erythrocytes (~ 120 days), reticulocytes have 
an average life span of 4 days, making the CHr a much more dynamic parameter 
compared to the standard erythrocytes indices. For adults, a CHr cut off value of < 28 
pg is used for the diagnosis of iron deficiency [10].
Group analysis
Based on literature and clinical guidelines regarding iron deficiency anemia [6, 10, 18], 
cut off values for MCV (< 80 fL) and CHr (< 28 pg, i.e., 1.74 fmol) were used to create 
PPA subgroups. For both parameters, this created three groups: a non-anemic control 
group and two ferrous fumarate-supplemented PPA groups, one with patients below 
the above mentioned cut off values and the other with patients above the cut off 
values. For all patients, parameter changes between T0 and T4 were calculated and 
expressed as delta-values (T4–T0, dHb, dMCV, dCHr). Normality of distribution of the 
individual parameters was verified using a one sample Kolmogorov–Smirnov test. 
Statistical analysis was performed using a paired (T0 vs. T4) T-test. Pearson’s product-
moment correlation coefficient was calculated to assess the association between 
MCV and CHr (SPSS PASW 17.0.2; IBM, New York, NY, USA).




Non-anemic vs. anemic women
Table 2 shows an overview of the changes in Hb, MCV, and CHr between T0 and T4 
in the non-anemic control and PPA group. Both the non-anemic and supplemented 
anemic group showed a significant increase in Hb at T4 when compared to T0 (p < 
0.001). This increase was more prominent in the anemic group compared to the non-
anemic control group, 3.4 vs. 1.6 g/dL, respectively. The increase in MCV in the PPA 
group at T4 is statistically significant compared to T0 (p < 0.001). However, the delta 
MCV of +1.2 fL falls within the 1.55% coefficient of variation (CV) of the MCV assay. In 
the PPA group, CHr at T4 did not (significantly) change compared to T0 (dCHr 0.0 pg). 
Table 2 Changes in iron deficiency laboratory parameters between T = 0 weeks (T0) and T = 4 weeks (T4) in the 
non-anemic control and PPA index group


































Abbreviations: PPA = postpartum anemia, Hb = hemoglobin, MCV = mean corpuscular volume, CHr = reticulocyte 
hemoglobin content
Data in columns T0 and T4 are shown as mean (SD)
*p < 0.001 vs. T0. 
Note: although at T0 150 women were included, some were lost to the study during follow-up at T4. Because of 
the preferred paired statistical analysis between T0 and T4, this lowered the group size (n) of the parameters.
PPA MCV subgroups
By dividing the PPA group at T0 in a microcytic (MCV < 80 fL) and normocytic (MCV 
≥ 80 fL) anemia subgroup, we created two MCV subgroups. Irrespective of the 
subdivision, both subgroups showed an increase in Hb at T4 of +2.9 and +3.4 g/dL for 
microcytic and normocytic PPA women, respectively (p < 0.001, Table 3). However, in 
microcytic PPA women, the increase in MCV (dMVC +2.7 fL) was significant (p < 0.001) 
and well outside the 1.55% CV of the assay. In contrast, the MCV of normocytic PPA 
women showed an insignificant increase of +0.7 fL (Table 3, Figure 1a).
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Table 3 Changes in Hb and MCV between T = 0 weeks (T0) and T = 4 weeks (T4) in the non anemic control, low 
MCV (< 80 fL) PPA, and normal MCV (≥ 80 fL) PPA group




PPA (MCV < 80 fL)
PPA (MCV ≥ 80 fL)
Non-anemic
PPA (MCV < 80 fL)








8.9   (1.0)
















Abbreviations: PPA = postpartum anemia, Hb = hemoglobin, MCV = mean corpuscular volume
Data in columns T0 and T4 are shown as mean (SD). 
*p < 0.001 vs. T0.
Figure 1a MCV from T = 0 weeks (T0) to T = 4 weeks (T4) in the non-anemic control, normal MCV (≥ 80 fL) PPA, 














T0 T4 T0 T4 
MCV (fL) 
Control PPA 
MCV  80 fL 
PPA 
MCV < 80 fL 
Mean (thick black lines) and individual (thin black lines) delta MCV (dMCV, T4–T0) in non-anemic control, PPA 
normal MCV (MCV ≥ 80 fL), and PPA low MCV subgroups (MCV < 80 fL)
T0: T = 0 weeks, T4: T = 4 weeks, NS: not signifi cant
*p < 0.001 vs. T0
PPA CHr subgroups
When anemic women were divided based on their CHr [e.g., low CHr (<28 pg) and 
normal CHr (≥ 28 pg)], no difference was found in the increase in Hb concentration at 
T4 (Table 4). The mean CHr at T0 in the low CHr subgroup was 26.1 pg and increased 
by +1.9 pg reaching the CHr cut off value of 28 pg at T4 (p < 0.001). Conversely, the CHr 
in the normal CHr subgroup (T0, 31.4 pg) decreased by -1.0 pg (p < 0.001, Figure 1b). 
The decrease in the PPA normal CHr subgroup was similar to the decrease in the non-
anemic control group (dCHr -0.8 pg, Table 4).
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Table 4 Changes in Hb and CHr between T = 0 weeks (T0) and T = 4 weeks (T4) in the non-anemic control, low CHr 
(< 28 pg) PPA, and normal CHr (≥ 28 pg) PPA group




PPA (CHr < 28 pg)
PPA (CHr ≥ 28 pg)
Non-anemic
PPA (CHr < 28 pg)








8.9   (1.1)
















Abbreviations: PPA = postpartum anemia, Hb = hemoglobin, CHr = reticulocyte hemoglobin content
Data in columns T0 and T4 are shown as mean (SD). 
*p < 0.001 vs. T0.
Figure 1b CHr T = 0 weeks (T0) to T = 4 weeks (T4) in the non-anemic control, normal CHr (≥ 28 pg) PPA, and low 







2.40 T0 T4 T0 T4 T0 T4 
CHr (fmol) 
Control PPA 
CHr  1.74 fmol 
PPA 





Mean (Thick black lines) and individual (thin black lines) delta CHr (dCHr, T4–T0) in non-anemic control, PPA 
normal CHr (CHr ≥ 28 pg), and PPA low CHr subgroups (CHr < 28 pg)
T0: T = 0 weeks, T4: T = 4 weeks
*p < 0.001 vs. T0
Note: the non-anemic control and PPA normal CHr showed a signifi cant decrease
MCV vs. CHr correlation
The baseline MCV and CHr values (T0) of all PPA women show a good correlation (R2 
= 0.663, p < 0.001, Figure 2). Despite an Hb of < 10.5 g/dL, 64% of the PPA women 
(89/140) (Figure 2, open dots) had baseline MCV and CHr values above their respective 
cut off values. 36% of the PPA women (51/140) (Figure 2, closed dots) had a microcytic 
MCV, a CHr below 28 pg, or both.
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60 70 80 90 100 
1.74 fmol 
R2 = 0.663 
MCV T0 (fL) 
CHr T0 (fmol) 
Figure 4 
Coeffi cient of correlation (R2) is 0.663 (p < 0.001). 
The vertical and horizontal dotted lines represent the respective cut off values of the MCV (80 fL) and CHr (28 pg). 
Open dots: normocytic MCV and CHr above cut off value. 
Filled dots: microcytic MCV, CHr below cut off value, or both.
Discussion
In PPA, it is assumed that the etiology of the anemia is attributed to iron defi ciency. 
Consequently, all PPA women with an Hb concentration between 6.5 and 10.5 g/
dL are orally supplemented with iron. This potentially results in unnecessary iron 
supplementation in those women with suffi cient iron stores. To evaluate the need for 
iron supplementation in women with mild PPA, we followed the therapeutic response 
to iron supplementation using accomplished cut off values for MCV and CHr.
Irrespective of baseline iron defi ciency parameters, the Hb concentration in all PPA 
women improved signifi cantly after 4 weeks (T4). This might be interpreted as a 
benefi cial therapeutic response to iron supplementation for all women with PPA.
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Indeed, the PPA MCV and CHr subgroups suggestive for depleted iron stores at T0 
showed a significant improvement for both MCV and CHr toward normalization at T4 
indicating a beneficial therapeutic response to iron supplementation. However, in the 
PPA MCV and CHr subgroups arguing against iron deficiency, no improvement in the 
respective parameters at T4 was seen. The lack of improvement of the MCV and CHr in 
these subgroups might be explained by the fact that the iron stores at T0 were already 
adequate and that no additional iron was taken up via the intestines.
The study is limited by the fact that all women with PPA were orally supplemented 
with iron, lacking a control group with PPA and normal iron stores who were not 
supplemented with iron. Because intestinal iron uptake is inhibited by hepcidin, 
which in turn is upregulated by adequate intracellular iron stores [19, 20], we assume 
that in the PPA group with sufficient iron stores no intestinal iron was taken up. 
Unfortunately, this remains an assumption because hepcidin concentrations were 
not measured in this study. Future studies are needed to confirm our findings. One 
such study would involve randomizing PPA women with adequate baseline iron 
stores (i.e., normal MCV and CHr ≥ 28 pg) creating PPA groups with and without iron 
supplementation. Confirming our results, one would expect both groups to show a 
similar increase in Hb, irrespective of supplementation.
The data of our study suggest that the assumption of iron deficiency as etiology of 
PPA is not always justified. Indeed, the majority of PPA women in our study (64%) 
had baseline laboratory parameters (i.e., normocytic MCV and CHr ≥ 28 pg) arguing 
against iron deficiency as the cause of the anemia and as a result were unnecessarily 
supplemented with iron.
The MCV and CHr can be readily analyzed in conjunction with an Hb concentration 
from the same sample. Therefore, next to Hb, we propose to include measurement of 
MCV and CHr, using standard cut off values, for identifying truly iron-deficient PPA 
women who will have a beneficial therapeutic response to iron supplementation, 
thereby reducing the needless supplementation of iron in those PPA women with 
sufficient iron stores.
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Chapter 7
A randomized controlled trial 
examining the addition of folic 
acid to iron supplementation in the 
treatment of postpartum anemia
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Objective: To evaluate the efficacy of adding folic acid to oral iron supplementation in 
postpartum women with anemia.
Methods: A randomized controlled trial was conducted in the Netherlands between 
April 8, 2008, and August 31, 2010. A total of 112 postpartum women with anemia 
(hemoglobin [Hb] < 10.5 g/dL) were randomly allocated to receive 600 mg/day ferrous 
fumarate plus 1 mg/day folic acid (FFFA group) or 600/day ferrous fumarate alone 
(FF group) for 4 weeks. Primary outcome measures were Hb and health status (HS). 
Secondary outcome measures were fatigue, compliance, and adverse reactions.
Results: Intention-to-treat analyses showed no interaction effects on Hb, HS and 
fatigue scores. The FFFA group showed a steeper increase on serum folate concen-
tration compared with the FF group (p < 0.0001). Hb significantly increased over time 
(p < 0.0001). Also, an overall time effect was observed for HS and fatigue, most scores 
improved. A group effect for the EQ-5D pain and discomfort scale (p < 0.0001) and 
VAS (p < 0.05) was observed. The FFFA group reported higher pain scores on the EQ-
5D and lower VAS scores compared with the FF group.
Only 50.5% of all women (n = 46) ingested all 84 prescribed ferrous fumarate tablets. 
Approximately 75% of all women reported having at least one symptom resulting 
from ferrous fumarate use. Constipation caused by ferrous fumarate was significantly 
associated with non-compliance (p = 0.014).
Conclusion: The addition of folic acid to iron supplementation is not beneficial in 
women with postpartum anemia, as it has no effect on hematologic or HS parameters.
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Introduction
Approximately 21% of women in high-income countries experience postpartum 
anemia, a condition characterized by tiredness, maternal infections, depression, and 
impairments in mother–child interactions and infant development [1–4]. Treatment 
of postpartum anemia could, therefore, contribute to maternal health and infant 
development. Health status (HS) is a multidimensional concept, which refers to 
self-perceived physical, mental, and social functioning, and can be assessed by 
standardized questionnaires [5]. 
For active erythropoiesis to take place, adequate supplies of folate, cobalamin (vitamin 
B12), and iron are needed [6]. A deficiency in any one of these can reduce erythrocyte 
production and, subsequently, the numbers of circulating erythrocytes; substantial 
reduction can result in anemia [6]. Folate and vitamin B12 are both required for 
the extensive DNA synthesis that accompanies the production of hundreds of 
billions of new erythrocytes each day [6]. A decrease in vitamin B12 concentration 
has been observed during pregnancy, but the concentration of the active moiety, 
holotranscobalamin, remains unchanged [7]. 
Pregnant women require supplementation with iron and folic acid because of the 
increase in maternal hematopoiesis, rapidly dividing cells in the fetus, and because 
of elevated urinary losses of these nutrients [8]. WHO recommends universal daily 
supplementation with 60 mg/day elemental iron and 400 μg/day folic acid for 6 
months during pregnancy and for the first 3 months postpartum to prevent iron-
deficiency anemia [9]. 
The management of postpartum anemia is unclear because of significant variations 
in treatment and outcome measures [10]. In a randomized controlled trial (RCT) [11], 
postpartum women with anemia treated with 80 mg/day ferrous iron, with or without 
0.35 mg/day folic acid, were compared with placebo. Hematological parameters 
and subjective health conditions improved significantly in both treatment groups; 
however, no difference was found between women who did and did not receive folic 
acid [11]. All women were selected during their third trimester of pregnancy, when 
their hemoglobin (Hb) levels were above 10 g/dL, and all started treatment after 
spontaneous delivery, without consideration of their Hb level at that time. In addition, 
subjective health was determined without the use of a standardized HS questionnaire.
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The aim of the present study was to determine whether the addition of folic acid to 
oral iron supplementation improved Hb and HS in women with postpartum anemia. 
The effect of these agents on fatigue, compliance with treatment, and adverse 
reactions was also determined.
Materials en methods
The present RCT was conducted between April 8, 2008, and August 31, 2010, at the 
Department of Obstetrics and Gynecology, TweeSteden Hospital, Tilburg, in the 
southern part of the Netherlands. Approval was obtained from the local ethics 
committee (file number NL21797.028.08). All women received verbal and written 
information about the study, and provided verbal and written informed consent.
Women were eligible for inclusion if they were 18 years or older, thoroughly 
understood the Dutch language, and had indications for Hb determination within 48 
hours after delivery. Indications included estimated blood loss over 500 mL, delivery 
by cesarean, manual removal of the placenta, and clinical symptoms of anemia. 
Women were excluded for the following reasons: Hb less than 6.4 g/dL (because 
the hospital protocol indicates the need for packed red cell transfusion); addiction 
to alcohol or drugs; hematological disease; vitamin B12 deficiency (serum vitamin 
B12 < 100 nmol/L and holotranscobalamin < 20 pmol/L); methotrexate use; and 
contraindications for folic acid and ferrous fumarate.
Within 48 hours postpartum (T0), maternal venous blood was collected to 
determine hematological parameters, and HS was measured using the self-reported 
standardized 36-item Short-Form Health Survey (SF-36), the European Quality of Life 
questionnaire (EQ-5D), and the Visual Analogue Scale (VAS) of the EQ-5D. Fatigue 
was measured using the Checklist Individual Strength (CIS).
Anemia was defined, according to Dutch guidelines, as Hb less than 10.5 g/dL [12]. 
Women were enrolled by random selection of opaque, taped envelopes containing 
a note reading “ferrous fumarate plus folic acid” (FFFA group) or “ferrous fumarate 
alone” (FF group). Doctors and the included women were not blinded to allocation as 
no placebo was used. All included women were prescribed 200 mg ferrous fumarate 
three times daily for 4 weeks, whereas women in the FFFA group were also prescribed 
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0.5 mg folic acid twice daily for 4 weeks. Women who did not have anemia (Hb ≥ 10.5 
g/dL) were excluded from randomization. 
Women were followed up at the outpatient clinic 5 weeks after delivery (T5), at which 
time hematological parameters and HS were again measured. Compliance with 
medication was measured by counting the numbers of remaining tablets. Adverse 
effects were assessed using a list of symptoms that frequently occur after ferrous 
fumarate or folic acid use. This list was completed by the women themselves during 
the follow-up appointment.
Blood Hb, erythrocyte mean corpuscular volume, erythrocyte volume fraction 
(hematocrit), erythrocyte mean corpuscular hemoglobin concentration, erythrocyte 
mean corpuscular hemoglobin, hemoglobin content in reticulocytes, and total 
reticulocyte count were analyzed using an Advia 2120i (Siemens Healthcare 
Diagnostics, Breda, Netherlands) automated cell counter. Total serum iron and total 
iron binding capacity (TIBC) were measured on an Advia 1650 chemistry analyzer 
(Siemens Healthcare Diagnostics). Transferrin concentration was measured on 
a Beckman Coulter Immage 800 immunochemistry analyzer (Beckman Coulter, 
Mijdrecht, Netherlands). Serum ferritin and folic acid were measured on an Advia 
Centaur immunoassay system (Siemens Healthcare Diagnositcs). Folic acid levels less 
than 7 nmol/L were considered indicative of folic acid deficiency.
Iron-deficiency anemia was defined as Hb less than 10.5 g/dL plus mean corpuscular 
volume less than 80 fL or hemoglobin content in reticulocytes less than 28 pg (1.74 
fmol) [13]. Hb, measured as mmol/L was converted to g/L by multiplying by 16.115, 
whereas Hb measured as g/L was converted to mmol/L by multiplying by 0.062054. 
Iron saturation was calculated as (serum iron/ total iron binding capacity) x 100%.
The SF-36 is a generic questionnaire that was chosen because it covers all HS domains, 
and is often used in determining HS in postpartum women. Each of the 36 items 
has a scoring range from 0 to 100, with higher scores representing better levels of 
functioning [14]. In addition, the SF-36 provides a physical component summary and 
a mental component summary.
The EQ-5D is a generic HS questionnaire containing five items, each with a scoring 
range from 1 to 3, with higher scores representing worse functioning [15]. Included 
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in the EQ-5D is the VAS, which represents a global evaluation of health on a scale 
ranging from 0 (worst imaginable health status) to 100 (best imaginable health 
status). This questionnaire was chosen because of its simplicity and rapid completion 
time. Both the SF-36 and EQ-5D have demonstrated good psychometric properties in 
postpartum women [16].
The CIS is a multidimensional scale that quantifies subjective fatigue and related 
behavioral aspects [17]. This questionnaire was chosen because fatigue is a symptom 
of anemia. Each of the 20 items is scored from 1 to 7, with higher scores indicating 
greater fatigue. CIS is a reliable and valid tool in people with chronic fatigue syndrome 
as well as in healthy populations [18].
The primary outcome measures were Hb and HS increases after 4 weeks of treatment. 
Secondary outcome measures were fatigue, compliance, and adverse reactions. 
Sample size calculation was based on the hypothesis that increases in Hb concentration 
and HS over time would be greater in the FFFA than in the FF group. A priori sample 
size calculation was carried out using analysis of variance for repeated measures by 
the G-power 3.1 calculator [19]. Assuming an effect size of 0.5, with an α-error of 0.05 
and a power of 80%, a total sample size of 26 participants was required. To be able to 
undertake sub-analyses, the sample size was expanded to include 112 women with 
anemia.
All statistical analyses were conducted using SPSS 15.0 (IBM, Armonk, NY, USA). 
Baseline characteristics, compliance, and adverse effects in the two groups were 
assessed using independent sample T tests or Chi square tests. All analyses were 
conducted according to intention-to-treat principles. ANOVA for repeated measures 
was used to compare the group who received folic acid with the group who received 
folic acid and oral iron supplementation on hematological parameters and HS and 
fatigue scores across time, with correction for the number of tests using the Bonferroni 
rule. All results are reported as mean ± standard deviation or percentage (%). p < 0.05 
was considered statistically significant.
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Results
The flow of participants through the study is shown in accordance with CONSORT 
criteria (Figure 1). Of the 364 women screened, 53 did not meet the inclusion criteria, 
42 were excluded owing to vitamin B12 deficiency, eight were excluded because 
Hb was less than 6.4 g/dL, and three were excluded owing to language constraints. 
Eleven women declined to participate. Eighty women did not complete the baseline 
HS questionnaires for unknown reasons, and were therefore excluded, as were 108 
women who did not have anemia (Hb ≥ 10.5 g/dL). As a result, 112 women were 
randomly allocated between the groups. Of these, 91 women were available for 
analyses because 12 were lost to follow up, and nine withdrew. 
Figure 1 Flow chart of patients
 
 



















Assessed for eligibility (n=364) 
Excluded (n=252) 
♦      Not meeting inclusion criteria (n=53) 
• vitamin B12 deficient (n=42) 
• Hb < 6.4 g/dL (n=8) 
• language barrier (n=3)  
♦      Declined to participate (n=11) 
♦      Incomplete HS questionnaires (n=80) 





♦      Lost to follow-up (no-show) (n=9) 
♦      Withdrawal (time shortage) (n=5) 
Allocated to ferrous fumarate plus folic 
acid (n=62) 
♦  Received allocated intervention (n=62)  
♦      Lost to follow-up (no-show) (n=3) 
♦      Withdrawal (time shortage) (n=4) 
Allocated to ferrous fumarate (n=50) 
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The demographic and clinical characteristics of the participants by treatment group 
are shown in Table 1. No relevant differences among the groups were detected at 
baseline. Each group included eight women with a serum folate deficiency at baseline 
(p = 0.64). Iron-deficiency anemia was present in 18 women in the FFFA group and 
21 in the FF group (29% vs 42%, p = 0.15).
Table 1 Patient demographic and clinical characteristics at baseline (T0) a




Age at entry (years) 31.0 ± 4.7 30.1 ±  4.5
BMI before pregnancy (kg/m2) 25.2 ± 4.7 25.3 ± 6.2
Caucasian 55 (88.7) 42 (84)
Highest education
   Lower 3 (5.2) 3 (6.1)
   Medium 29 (50) 27 (55.1)
   High 26 (44.8) 19 (38.8)
Smoking 9 (14.5) 6 (12.2)
Multivitamin or FA use 30 (48.4) 18 (36)
Parity at baseline 1.6 ± 0.9 1.4 ± 0.7
Gestational age at delivery 
(weeks)
40.0 ±1.6 40.0 ± 1.6
Delivery method
   Vaginal 40 (64.5) 30 (60.0)
   Cesarean section 22 (35.5) 20 (40.0)
Estimated blood loss (ml) 834 ± 436 811 ± 395
Infant feeding
   Breastfeeding 36 (58.1) 34 (68)
   Bottle (formula) feeding 26 (41.9) 16 (32)
Serum folate deficiency 8 (12.9) 8 (16)
Iron deficiency anemia 18 (29.0) 21 (42.0)
Abbreviations: BMI = Body Mass Index (calculated as weight in kilograms divided by the square of height in 
meters), FA = folic acid.
a Values are given as mean ± SD or number (percentage).
Intention-to-treat analyses on hematologic parameters showed no interaction 
effects, except for serum folate concentration (p < 0.0001, Table 2). The FFFA group 
showed a steeper increase on serum folate concentration compared with the FF group. 
Significant effects of time were found with regard to Hb (p < 0.0001), hematocrit (p < 
0.0001), mean corpuscular volume (p < 0.0001), mean corpuscular hemoglobin (p < 
0.008), mean corpuscular hemoglobin concentration (p < 0.0001), iron saturation (p 
< 0.0001), and TIBC (p < 0.0001). Hb, hematocrit, mean corpuscular volume, and iron 
saturation increased over time, while mean corpuscular hemoglobin, mean corpuscular 
hemoglobin concentration, and TIBC decreased. No group effect was observed.
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Table 2 Hematology results at baseline (T0) and after 4 weeks of treatment (T5) a




T0 T5 T0 T5
Hemoglobin, g/dL b 9.2 ± 0.9 12.4 ± 1.0 9.2 ± 0.9 12.2 ± 1.1
Hematocrit, % b 0.27 ± 0.03 0.38 ± 0.03 0.27 ± 0.03 0.37 ± 0.03
Mean corpuscular volume, fL b 84.3 ± 5.4 85.4 ± 5.7 82.7 ± 6.1 83.9 ± 5.4
Mean corpuscular hemoglobin, 
fmol b
1.76 ± 0.14 1.74 ± 0.14 1.73 ± 0.16 1.70 ± 0.13
Mean corpuscular hemoglobin 
concentration, mmol/L b
20.9 ± 0.6 20.5 ± 0.7 21.0 ± 0.6 20.3 ± 0.7
Serum Iron, μmol/L 11.7 ± 5.7 14.6 ± 8.0 12.2 ± 6.4 13.3 ± 10.4
Iron saturation, % b 15.8 ± 8.1 22.8 ± 13.2 15.8 ± 8.7 20.9 ± 16.5
Total iron binding capacity, 
μmol/L b
77.2 ± 14.8 64.9 ± 8.1 78.0 ± 11.1 66.3 ± 7.7
Ferritin, μg/L 32.1 ± 35.7 23.9 ± 9.0 22.5 ± 17.1 24.0 ± 12.3
Transferrin, g/L 3.7 ± 0.7 3.1 ± 0.4 3.7 ± 0.6 3.2 ± 0.5
Reticulocyte hemoglobin content, 
pg
1.87 ± 0.17 1.88 ± 0.18 1.86 ± 0.21 1.84 ± 0.18
Folic acid, nmol/l c 15.3 ± 8.7 34.1 ± 13.3 14.9 ± 11.1 19.4 ± 11.8
a Values are given as mean ± SD
b Repeated measures ANOVA: significant effect of time (p < 0.0001)
c Repeated measures ANOVA: interaction effect between FFFA and FF group (p < 0.0001)
Note: There were no significant differences between the FFFA and FF group on the other variables
In addition, intention-to-treat analyses on the SF-36, EQ-5D, and CIS scores showed 
no interaction effects (Table 3). However, an overall time effect was observed with 
regard to the SF-36 subscales physical functioning, social functioning, role physical, 
mental health, vitality, bodily pain, PCS, MCS, and total scores (p < 0.0001), the EQ-
5D subscales mobility, self care, daily activities, pain and discomfort, total scores, and 
VAS (p < 0.0001) and the CIS subscales subjective fatigue, motivation, and activity, 
and total scores (p < 0.0001). All scores improved. Also, a group effect for the EQ-5D 
pain and discomfort scale (p < 0.0001) and VAS (p < 0.05) was observed. The FFFA 
group reported higher pain scores on the EQ-5D and lower VAS scores compared with 
the FF group.
At 5 weeks postpartum, 72.3% (n = 34) of the women in the FFFA group and 66.7% 
(n = 28) of those in the FF group reached non-anemic Hb levels (> 12.0 g/dL) (p = 0.56). 
When women in the two groups were stratified by baseline severe (Hb 6.4–8.0 g/dL, 
n =  12) and moderate (Hb 8.0–10.5 g/dL, n = 77) anemia, no significant between-
group differences were found in the percentage of women with severe (p = 0.68) and 
moderate (p = 0.93) anemia attaining non-anemic Hb levels (Figure 2). 
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Table 3 Health status by group at baseline (T0) and after 4 weeks of treatment (T5) a
Ferrous Fumarate plus Folic Acid Ferrous Fumarate
T0 T5 T0 T5
SF-36
   Physical functioning b 39.8 ± 32.7 80.0 ± 18.7 43.4 ± 36.5 84.2 ± 16.2
   Social functioning b 64.3 ± 26.7 85.4 ± 19.2 71.5 ± 24.1 84.6 ± 23.3
   Role physical b 29.8 ± 38.9 64.9 ± 43.5 39.5 ± 38.3 74.4 ± 38.4
   Role emotional 86.5 ± 33.8 87.2 ± 32.3 84.1 ± 31.4 96.0 ± 51.2
   Mental health b 78.4 ± 15.5 86.9 ± 11.3 79.5 ± 11.7 85.5 ± 11.0
   Vitality b 52.8 ± 22.2 65.5 ± 15.7 56.9 ± 18.4 66.8 ± 15.0
   Bodily pain b 56.0 ± 30.1 81.5 ± 20.4 65.0 ± 28.0 87.2 ± 19.4
   General health 79.5 ± 15.3 79.7 ± 16.3 80.8 ± 11.6 80.3 ± 11.4
   Health change 45.3 ± 21.0 45.8 ± 22.1 44.2 ± 14.3 47.1 ± 14.6
   Physical component summary b 50.8 ± 20.8 76.5 ± 20.2 57.6 ± 22.0 81.7 ± 17.2
   Mental component summary b 70.1 ± 18.5 81.5 ± 15.7 73.1 ± 14.5 84.0 ± 18.3
   Total b 58.8 ± 16.6 75.3 ± 15.2 63.2 ± 15.4 78.7 ± 15.1
EQ-5D
   Mobility b 1.96 ± 0.71 1.17 ± 0.38 2.02 ± 0.77 1.07 ± 0.26
   Selfcare b 1.69 ± 0.62 1.04 ± 0.20 1.77 ± 0.72 1.00 ± 0.00
   Daily activities b 2.21 ± 0.68 1.38 ± 0.57 2.16 ± 0.81 1.28 ± 0.50
   Pain and discomfort b,c 1.94 ± 0.38 1.52 ± 0.55 1.70 ± 0.51 1.23 ± 0.43
   Anxiety and depression 1.17 ± 0.38 1.13 ± 0.33 1.16 ± 0.37 1.09 ± 0.29
   Total b 8.94 ± 2.05 6.23 ± 1.49 8.81 ± 2.49 5.67 ± 0.99
   Visual Analogue Scale b,d 65.7 ± 16.2 76.9 ± 12.4 71.1 ± 13.2 81.8 ± 9.3
Checklist Individual Strength
   Subjective fatigue b 36.9 ± 12.4 26.6 ± 11.5 33.3 ± 12.4 25.8 ± 10.0
   Reduced motivation b 13.1 ± 6.1 8.1 ± 3.3 13.1 ± 5.4 9.2 ± 4.0
   Reduced activity b 12.2 ± 5.6 7.8 ± 4.4 11.4 ± 5.5 8.4 ± 3.6
   Reduced concentration 15.8 ± 8.1 13.2 ± 8.0 14.4 ± 6.9 13.6 ± 7.3
   Total b 77.7 ± 27.5 55.8 ± 21.8 71.6 ± 25.0 57.1 ± 18.7
a Values are given as mean ± SD
b Repeated measures ANOVA: significant effect of time (p < 0.0001)
c Repeated measures ANOVA: significant group effect (p < 0.0001)
d Repeated measures ANOVA: significant group effect (p < 0.05)
Note: There were no effects with regard to the other variables
None of the women experienced serious adverse effects. However, 74.7% (n = 68) of 
all women, 77.1% in the FFFA (n = 37), and 72.1% in the FA group (n = 31) (p = 0.58) 
reported having at least one symptom as a result of ferrous fumarate use. The most 
common of these symptoms was colored feces and constipation, which were reported 
by 64.8% (n = 59) and 38.5% (n = 35) of these women, respectively. Only two women 
(4.3%) in the FFFA group reported skin rash as a result of folic acid use.
Of the women in both groups, 50.5% (n = 46) ingested all 84 prescribed ferrous 
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fumarate tablets and 76.7% (n = 69) ingested more than 75% (> 63 tablets). Of the 
women in the folic acid group, 62.5% (n = 30) ingested all 56 prescribed folic acid 
tablets, and 79.2% (n = 38) ingested more than 75% (> 42 tablets). Constipation 
caused by ferrous fumarate was associated with non-compliance. Women without 
constipation ingested 20 or more ferrous fumarate tablets than women with 
constipation (p = 0.014).No association was found between folic acid compliance and 
skin rash (p = 0.28).
Figure 2 Number of women per group with hemoglobin over 12.0 g/dL at 5 weeks postpartum 
No. of 
women






















In the present RCT, the addition of folic acid to iron supplementation did not confer 
additional benefit, as shown by Hb concentration and HS in women with postpartum 
anemia. Fatigue scores were also not affected by folic acid addition. Approximately 
75% of the women in this trial reported having at least one symptom arising from 
ferrous fumarate use, with constipation caused by ferrous fumarate significantly 
associated with non-compliance. 
An earlier RCT also found no difference in hematological parameters and subjective 
health conditions between postpartum women who did and did not receive folic acid, 
but probably also included women without postpartum anemia [11]. In contrast, an 
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RCT in anemic pregnant women in Mexico found that Hb levels were higher after iron 
and folic acid supplementation than after iron supplementation alone; those results 
were independent of serum folate concentrations [20]. The differences in diet and 
socioeconomic status between Mexican and European populations make it difficult 
to compare these findings with those of the present study.
Approximately 75% of all the women in this trial experienced an adverse effect of ferrous 
fumarate, which is higher than the 56% reported in a study involving pregnant women 
[21]. This difference may be attributable to the higher ferrous fumarate dose used in the 
present study, as adverse effects are dose related [22]. Iron dosage in the present study, 
however, was consistent with the recommended dosage of 100–200 mg/day ferrous iron 
in women with slight-to-moderate postpartum anemia [23]. Non-compliance owing to 
gastrointestinal adverse effects is consistent with previous findings [22].
Although the study participants were randomized between the two treatment arms, 
the results of randomization were not blinded, and therefore may have influenced 
study outcomes. Serum folic acid concentration, however, increased significantly over 
time in the FFFA group compared with the FF group, suggesting that the lack of placebo 
did not alter the results substantially. Although central randomization is generally 
recommended, participants in the present study were randomized using concealed 
opaque envelopes. There is no evidence, however, that the use of these envelopes 
differed from central randomization [24]. Hematology outcomes were only measured 
up to 5 weeks after delivery. These outcomes may have been different after a longer 
follow-up period. As erythroblast maturation takes 5–7 days, however, any between-
group difference in Hb concentrations would have been detected after 5 weeks [25].
Because this study included women of different ages, educational levels, parity, and 
modes of delivery, the results are applicable in daily medical practice. The addition of 
folic acid to iron supplementation does not benefit women with postpartum anemia, 
and is not required in daily practice in high-income countries. The present study was 
conducted in the Netherlands, and most women were white with western dietary 
habits; therefore, these results cannot be extrapolated to low-income countries.
In conclusion, the addition of folic acid to iron supplementation does not improve Hb, 
HS, and fatigue in women with postpartum anemia. Oral iron supplementation was 
associated with a high rate of adverse effects, such as constipation. Constipation was 
significantly associated with non-compliance.
33558 Woude, Daisy CS6.indd   104 27-04-15   16:18
7
Adding folic acid to iron in the treatment of postpartum anemia
105
References
1.  Bergmann, R.L., Richter, R., Bergmann, K.E., et al., Prevalence and risk factors for early postpartum anemia. 
Eur J Obstet Gynecol Reprod Biol 2010;150(2):126–31.
2.  Dodd, J., Dare, M.R., and Middleton, P., Treatment for women with postpartum iron deficiency anaemia. 
Cochrane Database Syst Rev 2004;4:CD004222.
3.  Corwin, E.J., Murray-Kolb, L.E., and Beard, J.L., Low hemoglobin level is a risk factor for postpartum 
depression. J Nutr 2003;133(12):4139–42.
4.  Perez, E.M., Hendricks, M.K., Beard, J.L., et al., Mother-infant interactions and infant development are 
altered by maternal iron deficiency anemia. J Nutr 2005;135(4):850–5.
5.  Hamming, J.F., and De Vries, J., Measuring quality of life. Br J Surg 2007;94(8):923–4.
6.  Koury, M.J., and Ponka, P., New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu 
Rev Nutr 2004;24:105–31.
7.  Morkbak, A.L., Hvas, A.M., Milman, N., et al., Holotranscobalamin remains unchanged during pregnancy. 
Longitudinal changes of cobalamins and their binding proteins during pregnancy and postpartum. 
Haematologica 2007;92(12):1711–2.
8.  Pena-Rosas, J.P., and Viteri, F.E., Effects of routine oral iron supplementation with or without folic acid for 
women during pregnancy. Cochrane Database Syst Rev 2006;3:CD004736.
9.  International Nutritional Anemia Consultative Group (INACG), World Health Organization (WHO), United 
Nations Children’s Fund (UNICEF). Guidelines for the use of iron supplements to prevent and treat iron 
deficiency anaemia. http://www.who.int/nutrition/publications/micronutrients/guidelines_for_Iron_
supplementation.pdf. Published 1998.
10. Parker, J.A., Barroso, F., Stanworth, S.J., et al., Gaps in the evidence for prevention and treatment of maternal 
anaemia: a review of systematic reviews. BMC Pregnancy Childbirth 2012;12:56.
11. Mára, M., Zivný, J., Eretová, V., et al., Changes in markers of anemia and iron metabolism and how they are 
influenced by antianemics in postpartum period. Acta Obstet Gynecol Scand 2001;80(2):142–8.
12. Jans, S., and Beentjes, M. Anemia in obstetric practice. Recommendations for prevention, diagnosis 
and treatment. KNOV standard. http://dutchmidwife.com/docs/uploads/Standaard_Anemie_in_de_
verloskundige_praktijk_2010.pdf.  Published November 2010.
13. Ramakers, C., van der Woude, D.A., Verzijl, J.M., et al., An added value for the hemoglobin content in 
reticulocytes (CHr) and the mean corpuscular volume (MCV) in the diagnosis of iron de!ciency in postpartum 
anemic women. Int J Lab Hematol 2012;34(5):510–6.
14. Ware, J.E., SF-36 health survey update. Spine (Phila Pa 1976) 2000;25(24):3130–9.
15. Brooks, R., EuroQol: the current state of play. Health Policy 1996;37(1):53–72.
16. Jansen, A.J., Essink-Bot, M.L., Duvekot, J.J., et al., Psychometric evaluation of health-related quality of life 
measures in women after different types of delivery. J Psychosom Res 2007;63(3):275–81.
17. Vercoulen, J.H., Swaninck, C.M., Fennis, J.F., et al., Dimensional assessment of chronic fatigue syndrome. J 
Psychosom Res 1994;38(5):383–92.
18. Vercoulen, J.H., and Bleijenberg, G., Kort instrumenteel: de Checklist Individual Strength (CIS). 
1999;32(2):131–6.
19. Faul, F., Erdfelder, E., Lang, A.G., et al., G*Power 3: a flexible statistical power analysis program for the social, 
behavioral, and biomedical sciences. Behav Res Methods 2007;39(2):175–91.
20. Juarez-Vazquez, J., Bonizzoni, E., and Scotti, A., Iron plus folate is more effective than iron alone in the 
treatment of iron deficiency anaemia in pregnancy: a randomised, double blind clinical trial. BJOG 
2002;109(9):1009–14.
21. Melamed, N., Ben-Haroush, A., Kaplan, B., et al., Iron supplementation in pregnancy–does the preparation 
matter? Arch Gynecol Obstet 2007;276(6):601–4.
22. Zhou, S.J., Gibson, R.A., Crowther, C.A., et al., Should we lower the dose of iron when treating anaemia in 
pregnancy? A randomized dose-response trial. Eur J Clin Nutr 2009;63(2):183–90.
23. Milman, N., Postpartum anemia II: prevention and treatment. Ann Hematol 2012;91(2):143–54.
24. Herbison, P., Hay-Smith, J., and Gillespie, W.J., Different methods of allocation to groups in randomized trials 
are associated with different levels of bias. A meta-epidemiological study. J Clin Epidemiol 2011;64(10):1070–5.
25. Pathobiology of the Human Erythrocyte and Hemoglobins. In: Hoffman, R., Benz Jr, E.J., Silberstein, L.E., et 
al., editors. Hematology: Basic Principles and Practice. 6th ed. London: Elsevier Health Sciences; 2012.


















Chapterblad Proefschrift Daisy 17x24 grijs.pdf   1   27-04-15   15:21


















Chapterblad Proefschrift Daisy 17x24 grijs.pdf   1   27-04-15   15:21
Chapter 8
General discussion




Despite the fact that micronutrient deficiency is a common problem [1, 2], which was 
found to be associated with impaired health status (HS) and quality of life (QOL), 
and increased fatigue [3-7], the impact of micronutrient deficiency on maternal 
HS and fatigue is a neglected topic. Therefore, this thesis examined QOL and HS in 
postpartum women, and the impact of postpartum micronutrient status on maternal 
HS and fatigue. We examined anemia, iron, folic acid, vitamin B12, and vitamin D in 
association with HS and fatigue in postpartum women.
We showed in our systematic review (chapter 2) that studies concerning the 
association of micronutrient deficiency with postpartum HS and QOL are lacking. 
Since anemia and vitamin D deficiency were found to be associated with impaired HS 
[5, 7] and increased fatigue [3, 4, 6] in the current literature, we examined whether this 
association also existed in postpartum women. We compared postpartum HS and 
fatigue between anemic and non-anemic women, and women with sufficient and 
insufficient vitamin D levels. 
Surprisingly, no differences were observed in HS and fatigue scores between 
postpartum women with or without anemia (chapter 3). To our knowledge, this is 
the first study to compare all domains of HS and fatigue (physical, mental, and social 
functioning) in postpartum women with and without anemia. In agreement with an 
earlier study, we found that HS and fatigue scores improved over time in all groups 
and were not associated with hemoglobin (Hb) level [8].
The results of our study may be explained by the fact that postpartum anemia 
was based on Hb level within 48 hours after delivery, when a low Hb level can be 
physiological. Hb level decrease during pregnancy is caused by hypervolemia and 
hemodilution [9, 10]. Postpartum, increased diureses eliminates the excess plasma 
volume, leading to hemoconcentration and an increase of Hb concentration from 
the third postpartum day to prepartum values at one week postpartum and to 
normal values at four weeks postpartum [10]. Recently, no improvement of HS 
and fatigue were found after red blood cell transfusion in severe acute postpartum 
anemic women (Hb 4.8 – 7.9 g/dL) compared with non-intervention [11]. All included 
women had ≥ 1000 ml blood loss and/or a decrease in Hb concentration of ≥ 1.9 
g/dL. In this study, anemia was based on Hb level within 24 hours after peripartum 




hemorrhage. Therefore, we conclude that HS and fatigue are not associated with 
anemia based on Hb level.
Another explanation for the fact that we did not find a difference in HS and fatigue 
between postpartum women with or without anemia, may be that the vast majority 
of our anemic postpartum women were not iron deficient (chapter 6). That means that 
the cause of anemia in our postpartum women was not iron deficiency, but another 
etiology. Besides hemodilution [9, 10] or peripartum hemorrhage [9, 11], postpartum 
anemia can also be due to deficiencies in micronutrients for erythropoiesis such as 
iron, folic acid, or vitamin B12 [9, 12]. In the current literature, iron deficiency (anemia) 
in particular, seems to be the major component associated with decreased physical 
and work capacity [13-15], reduced cognition [16, 17], and decreased HS [7]. We believe 
that iron deficiency anemia postpartum may result in an impaired HS and fatigue. 
As far as we know, there are no data comparing HS and fatigue between postpartum 
anemic women with or without iron deficiency. In only one RCT the difference in 
cognition, mood, and behavior among postpartum women with iron deficiency 
anemia and non-anemic women was examined  between 10 weeks and 9 months 
postpartum [18]. The iron deficient anemic women were randomized between 
vitamin C and folic acid supplementation (placebo group), and oral iron, vitamin 
C, and folic acid supplementation (iron supplementation group). After treatment, 
significantly more women in the placebo group than in the iron supplementation 
group were still anemic. At baseline, no significant differences in cognition, mood 
and behavior were observed between iron deficient anemic women compared with 
non-anemic women. After treatment, cognition, mood, and behavior improved 
in the iron supplemented group when compared to the placebo and non-anemic 
group. However, this study was performed among poor women in South Africa, who 
consumed < 75% of estimated daily requirements for nutrient intake. Therefore, these 
results cannot be extrapolated to postpartum anemic women in The Netherlands, 
as it is a high-income country with other dietary habits and nutritional status. Also, 
even though there were no significant differences in dietary intake patterns between 
the groups, vitamin C and folic acid level were not determined between the groups. 
Therefore, the observed improvements in the iron supplemented group could also 
be explained by a reduced vitamin C and folic acid before treatment. In conclusion, 
this placebo controlled RCT has a number of weaknesses, making it not applicable 
for daily practice in The Netherlands. Additional studies are needed to compare all 
three domains of HS (physical, mental, and social), multidimensional fatigue scores, 
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cognition, mood, and behavior among postpartum women with iron deficiency 
anemia before and after iron supplementation or placebo treatment.
The existing literature has shown an association of impaired HS and increased fatigue 
with vitamin D deficiency [3-5]. In this thesis, HS and fatigue were not different 
among postpartum women with sufficient and insufficient vitamin D levels (chapter 
4). These findings can be explained by the influence of other factors on HS and fatigue 
in the postpartum period, such as cesarean section (chapter 2) or exhaustion caused 
by infant crying [19]. Despite the fact that a similar prevalence of insufficient vitamin 
D levels among lactating and bottle feeding women was found (chapter 4), we believe 
that vitamin D supplementation should only be reserved for lactating postpartum 
women, as was recommended by international guidelines [20, 21] because the 
newborn relies on vitamin D supply from maternal breast milk.
We have already shown that anemia based on Hb level was not related to postpartum 
HS and fatigue, but we also examined the role of iron, folic acid, and vitamin B12 levels 
in postpartum women. We found that even though vitamin B12 deficiency was highly 
prevalent directly postpartum, based on serum vitamin B12 and holotranscobalamine 
(holoTC), this deficiency spontaneously resolved at 5 weeks postpartum (chapter 5). 
The fraction of active vitamin B12 (holoTC/total vitamin B12) was significantly higher 
in vitamin B12 deficient women at both time points and across time (chapter 5), 
suggesting that a shift occurs towards the metabolic active vitamin B12 (holoTC) 
in women with insufficient available total vitamin B12. Our results confirm the 
hypothesis that the changes of vitamin B12 levels during pregnancy and postpartum 
are physiologic and based on redistribution [22, 23]. In our opinion, screening for 
vitamin B12 deficiency is unnecessary in postpartum women without risk factors 
for true vitamin B12 deficiency. Postpartum women do not need vitamin B12 
supplementation, since vitamin B12 deficiency spontaneously resolves.
International guidelines regarding treatment of postpartum anemia do not 
discriminate between the etiologies of anemia. Based on Hb concentration, these 
guidelines recommend oral iron supplementation for mild to moderate postpartum 
anemia [24-26] because of its low cost and ease of use [27]. Despite the fact that 
oral iron supplementation seems harmless, many postpartum women experience 
adverse effects such as constipation, which results in non-compliance (chapter 7). 
Since, iron absorption from the gut is inhibited if iron stores are sufficient [28], iron 




supplementation could result in overtreatment in postpartum women without iron 
deficiency anemia. We examined the prevalence of iron deficiency in postpartum 
anemic women by using mean corpuscular volume (MCV) and reticulocyte 
hemoglobin content (CHr), and found that only 36% of the women were iron deficient 
(chapter 6). There was a significant Hb concentration increase in all anemic and non-
anemic women over time. No difference in Hb concentration increase was observed 
between anemic women with and without iron deficiency. However, anemic women 
with iron deficiency showed a significant improvement towards normalization of the 
MCV and CHr parameters, while the anemic women without iron deficiency did not 
show a significant increase in the MCV and CHr parameters. These results show that 
only iron deficient anemic women benefit from oral iron supplementation. In order 
to prevent overtreatment with oral iron supplementation in postpartum anemic 
women, MCV or CHr measurement in addition to Hb concentration is needed.
Folic acid in addition to oral iron supplementation is recommended and applied 
in order to prevent and treat postpartum anemia [2, 27, 29, 30]. We showed in our 
RCT that the addition of folic acid to oral iron supplementation is not beneficial in 
the treatment of postpartum anemia, as it has no effect on hematological, HS and 
fatigue parameters (chapter 7). A RCT performed by Mará et al. found no difference 
in hematological parameters and subjective health conditions between postpartum 
women who did and did not receive folic acid [31]. However, the study probably 
also included postpartum women without anemia and subjective health was 
determined without the use of a standardized HS questionnaire. In contrast, Juarez-
Vazques et al. performed a RCT in anemic pregnant women in Mexico and found 
that Hb levels were higher after iron and folic acid supplementation than after iron 
supplementation alone [32]. However, the study was performed in pregnant women 
instead of postpartum women and the difference in diet and socioeconomic status 
between Mexican and European populations makes it impossible to extrapolate 
the results of these studies to postpartum anemic women in The Netherlands. The 
strength of our study is the heterogeneous population, including women of different 
ages, educational levels, parity, and modes of delivery. Therefore, the results of our 
study are applicable in daily medical practice in The Netherlands. We conclude that 
the addition of folic acid to oral iron supplementation is not required in high-income 
countries. As a result, the guidelines should be changed to reflect our findings. This 
will reduce health care costs. 
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Clinical implications and future perspectives
Even though vitamin D insufficiency and anemia are highly prevalent in postpartum 
women, we showed that they do not influence maternal HS and fatigue. In accordance 
with the international guidelines, we recommend vitamin D supplementation in 
lactating women because the newborn relies on vitamin D supply from maternal 
breast milk [20, 21].
The association of treatment of postpartum anemia and the impact on maternal HS 
and fatigue has not been fully clarified. In this thesis, we have contributed to this 
knowledge by concluding that the addition of folic acid to oral iron supplementation 
is not required in high-income countries. As a result, the guidelines should be changed 
to reflect our findings. This will reduce health care costs.
Recently, it was concluded that red blood cell transfusion has to be restricted to 
postpartum anemic women with severe anemic symptoms, severe comorbidities, or 
circulatory instability, as it does not improve maternal HS and fatigue [11]. Postpartum 
anemia based on Hb alone was not associated with maternal HS and fatigue. The 
current guidelines recommend iron supplementation in postpartum anemic women 
based on Hb level, but our study implicates that this could lead to overtreatment. We 
found that only 36% of the postpartum anemic women were iron deficient. These 
women probably have the most benefit from iron supplementation. After oral iron 
supplementation, iron status improved in our iron deficient anemic women. Also, 
previous studies showed that iron deficiency with or without anemia was associated 
with decreased physical and work capacity [13-15], reduced cognition [16, 17], and 
decreased HS [7] in the general population.
Based on our study we believe that iron supplementation should be reserved for 
postpartum anemic women with iron deficiency. To examine this hypothesis, a 
randomized controlled trial is needed to compare all three domains of HS (physical, 
mental, and social), multidimensional fatigue scores, cognition, mood, and behavior, 
among postpartum women with iron deficiency anemia before and after iron 
supplementation or placebo treatment. MCV and CHr should be used to define iron 
deficiency.
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Chapter 1 provides a general introduction on quality of life (QOL), health status 
(HS) and fatigue in relation to postpartum micronutrient deficiency and anemia. In 
addition, the research questions of this thesis are outlined.
During pregnancy, maternal physiological changes and fetal demands for growth and 
development increase the requirements for micronutrients. Micronutrient deficiency 
is a common problem in both developing and developed countries. Iron, folic acid, 
and vitamin B12 are required for the production of red blood cells. Deficiency of one 
of these micronutrients can lead to anemia. Anemia and vitamin D deficiency can 
lead to fatigue and reduced HS and/or QOL. So far, these associations have not been 
studied in postpartum women. 
Health care is becoming more and more patient centered. Therefore, patient-reported 
outcomes become increasingly important. In this thesis, we investigated whether 
anemia and vitamin D deficiency are associated with reduced HS and increased 
fatigue in postpartum women. We also investigated the iron status and the effect 
of folic acid supplementation in anemic postpartum women. Finally, the course of 
vitamin B12 deficiency in the first postpartum weeks was investigated.
Chapter 2
The results are described of a systematic review regarding QOL and HS in postpartum 
women. Only studies in which at least the physical, mental and social domains 
were described, were included in the review (n = 66). The aspects that were most 
studied in postpartum women were: urine incontinence, cesarean section, human 
immunodeficiency virus (HIV), and depression. In none of the studies a control group 
of healthy fertile women was included, hence results are difficult to interpret. 
Regarding studies related to micronutrient deficiency in postpartum women, only 
two randomized controlled trials could be included. These studies examined anemia 
in postpartum women. Due to differences in treatment and hemoglobin (Hb) cutoff 
values, results could not be compared. 
Chapter 3
HS and fatigue were compared between women with and without postpartum 
anemia in this prospective cohort study of postpartum women. The anemic women 
(n = 112) were treated with oral iron supplementation with or without folic acid. Non-




anemic women (n = 108) received no treatment and were prospectively followed 
during the study. After adjustment for confounders (including cesarean section), 
no difference was found in HS and fatigue between the anemic and non-anemic 
postpartum women. In all women HS and fatigue scores improved significantly over 
time (p < 0.0001). Linear regression analysis showed no association of anemia and the 
amount of blood loss with any of the HS and fatigue scores within 48 hours and at 5 
weeks postpartum. 
It was concluded that there was no difference in HS and fatigue between anemic and 
non-anemic postpartum women. Overall, HS and fatigue improved over time in all 
postpartum women.
Chapter 4
In this chapter the prevalence of postpartum vitamin D sufficiency and insufficiency 
between breastfeeding and bottle feeding with their associated HS and fatigue are 
described. Vitamin D insufficiency was not different between breastfeeding and 
bottle feeding groups (57% vs. 64%, p = 0.46). There were no significant differences in 
HS and fatigue among breastfeeding women with or without vitamin D insufficiency. 
When bottle feeding, women with insufficient vitamin D scored significantly worse 
on the general health scale (p = 0.035). This finding is probably due to chance or the 
effect of multiple testing, because this difference was not found in breastfeeding 
women. 
In conclusion, maternal vitamin D status is not associated with breastfeeding or 
bottle feeding, and HS and fatigue are not associated with maternal vitamin D status. 
Chapter 5
The prevalence of vitamin B12 deficiency postpartum based on total vitamin B12 
and the metabolic active vitamin B12 (holotranscobalamine) was described in this 
chapter. Also, the hypothesis that a shift occurs towards holotranscobalamin in 
postpartum women with insufficient available total vitamin B12 was examined. In 
171 postpartum women, the fraction of active vitamin B12 (holotranscobalamin/
total vitamin B12) was compared between vitamin B12 deficiency and not deficiency. 
Vitamin B12 deficiency showed a spontaneous improvement of 60-75% within 48 
hours postpartum to 6-10% at 5 weeks postpartum. The fraction of active vitamin B12 
was significantly higher in vitamin B12 deficient women compared to women who 
were not vitamin B12 deficient (p < 0.0001). 
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In conclusion, there appears to be a shift in the direction of the metabolic active 
holotranscobalamine in women with insufficient available total vitamin B12. These 
results suggest that the changes of postpartum vitamin B12 are physiologically and 
are explained by redistribution. 
Chapter 6
In this chapter the usability of mean corpuscular volume (MCV) and reticulocyte 
hemoglobin content (CHr) to diagnose iron deficiency in postpartum anemic women 
was described. In a prospective cohort, anemic women were subdivided in microcytic 
(MCV < 80 fL, n = 30) and normocytic (MCV ≥ 80 fL, n = 85), or low CHr (< 28 pg, n = 
30) and normal CHr (≥ 28 pg, n = 75). Only 36% of anemic women were iron deficient. 
All anemic women were treated with ferrous fumarate with or without folic acid for 
4 weeks. No difference in Hb level increase was observed between the iron deficient 
and non-iron deficient groups. Women with iron deficiency showed significant 
improvement in the direction of normalization of MCV and CHr parameters, while 
non-iron deficient women did not show this increase. 
In conclusion, a combination of Hb with MCV or CHr can identify an actual iron 
deficiency in postpartum anemic women. 
Chapter 7
In this chapter the results of a randomized controlled trial are described in which 
112 postpartum women with anemia were randomly assigned to receive either 600 
mg ferrous fumarate plus 1 mg folic acid  per day (n = 48) or 600 mg/day ferrous 
fumarate alone (n = 43) for 4 weeks. After treatment, no differences were observed 
in Hb level, HS, and fatigue between the groups. About 75% of all women reported at 
least one adverse reaction due to ferrous fumarate use. Constipation was significantly 
associated with discontinuation of ferrous fumarate intake (p = 0.014). 
In conclusion, the addition of folic acid to oral iron supplementation is not beneficial in 
the treatment of postpartum anemia, as it has no effect on hematologic parameters, 
HS and fatigue.
Chapter 8
In chapter 8, the general discussion, conclusions and clinical implications of this 
thesis are displayed. The role of vitamin D, anemia, iron, folic acid and vitamin B12 in 
association with HS and fatigue are described.




Vitamin D insufficiency occurs in approximately 60% of postpartum women and is 
not associated with HS, fatigue, and infant feeding method. Because the newborn 
relies on vitamin D supply from maternal breast milk, vitamin D supplementation 
should be used in lactating women. 
Postpartum anemia based on Hb level alone, is not associated with HS and fatigue. 
The treatment of postpartum anemia generally consists of oral iron supplementation 
with or without the addition of folic acid. However, the addition of folic acid to the 
supplementation of oral iron in the treatment of postpartum anemia is not beneficial 
with respect to Hb level, HS, and fatigue in developed countries. In addition, only 36% 
of postpartum anemic women have an iron deficiency. To avoid overtreatment and 
unnecessary side effects, iron supplementation should be reserved for postpartum 
anemic women with iron deficiency. A combination of Hb with MCV or CHr should be 
used to diagnose iron deficiency anemia postpartum.
Vitamin B12 deficiency is common immediately postpartum, but spontaneously 
disappear five weeks postpartum. This change is physiologically and due to 
redistribution. Postpartum women without risk factors or manifestations of an actual 
vitamin B12 deficiency do not need vitamin B12 supplementation.





Hoofdstuk 1 geeft een algemene inleiding over kwaliteit van leven, gezondheidsstatus 
en vermoeidheid in relatie tot postpartum micronutriënten deficiëntie en anemie. 
Daarnaast wordt een overzicht gegeven van de onderzoeksvragen die in dit 
proefschrift worden onderzocht. 
Tijdens de zwangerschap ontstaat een toegenomen behoefte aan micronutriënten 
die noodzakelijk zijn om te voldoen aan de fysiologische maternale veranderingen en 
de foetale groei en ontwikkeling. Micronutriënten deficiëntie is een veel voorkomend 
probleem in zowel ontwikkelingslanden als ontwikkelde landen. Voor de aanmaak 
van rode bloedcellen zijn ijzer, foliumzuur en vitamine B12 nodig. Tekort aan één van 
deze micronutriënten kan leiden tot anemie. Anemie en tekort aan vitamine D kunnen 
leiden tot vermoeidheid en een vermindering van gezondheidsstatus en/of kwaliteit 
van leven. Deze associaties zijn bij vrouwen postpartum nooit eerder onderzocht. 
Patiënt gerichtheid in de gezondheidszorg staat steeds meer centraal. 
Hierdoor worden patiënt-gerapporteerde uitkomsten zoals kwaliteit van leven, 
gezondheidsstatus en vermoeidheid steeds belangrijker. In dit proefschrift 
onderzochten we of anemie en tekort aan vitamine D geassocieerd zijn met 
een verminderde gezondheidsstatus en een toegenomen vermoeidheid bij 
postpartum vrouwen. Tevens onderzochten we de ijzerstatus en het effect van 
foliumzuursuppletie bij anemische vrouwen postpartum. Tot slot werd het beloop 
van vitamine B12 deficiëntie in de eerste weken postpartum onderzocht.
Hoofdstuk 2
In hoofdstuk 2 worden de resultaten beschreven van een systematisch 
literatuuroverzicht over de kwaliteit van leven en de gezondheidsstatus van 
postpartum vrouwen. Enkel studies waarin ten minste de fysieke, mentale en sociale 
domeinen waren beschreven, werden geïncludeerd in de review (n = 66). De aspecten 
die het meest waren onderzocht bij postpartum vrouwen betroffen: incontinentie, 
sectio caesarea, humaan immunodeficiëntie virus (HIV) dragerschap en depressie. 
In geen van de studies werd een controlegroep met gezonde vruchtbare vrouwen 
geïncludeerd, waardoor de resultaten lastig te interpreteren zijn. Ten aanzien van 
studies met betrekking tot micronutriënten deficiëntie bij postpartum vrouwen, 
konden slechts twee gerandomiseerde gecontroleerde studies worden geïncludeerd. 
Deze studies onderzochten het effect van de behandeling van postpartum anemie. 




Door verschillen in behandeling en in hemoglobine afkapwaarden konden de 
resultaten niet worden vergeleken. 
Hoofdstuk 3
In hoofdstuk 3 worden de resultaten beschreven van een prospectieve cohort studie bij 
postpartum vrouwen. Gezondheidsstatus en vermoeidheid werden vergeleken tussen 
vrouwen met en zonder postpartum anemie. De anemische vrouwen (n = 112) werden 
behandeld met orale ijzer suppletie met of zonder foliumzuur. Niet-anemische 
vrouwen (n = 108) werden niet behandeld en werden prospectief vervolgd tijdens de 
studie. Na correctie voor confounders (inclusief sectio caesarea) werd geen verschil 
gevonden in gezondheidsstatus en vermoeidheid tussen de anemische en niet-
anemische postpartum vrouwen. Bij alle vrouwen verbeterden de gezondheidsstatus 
en vermoeidheid scores aanzienlijk na verloop van tijd (p < 0.0001). Lineaire regressie 
analyse toonde geen associatie van anemie en de hoeveelheid bloedverlies met de 
scores van de gezondheidsstatus- en vermoeidheidschalen binnen 48 uur en bij 5 
weken na de bevalling. 
Kortom, er werd geen verschil gezien in gezondheidsstatus en vermoeidheid tussen 
anemische en niet-anemische vrouwen. Alle vrouwen lieten duidelijke verbetering 
zien tijdens de eerste weken na de bevalling.
Hoofdstuk 4
In hoofdstuk 4 wordt de prevalentie beschreven van postpartum vitamine D 
sufficiëntie en insufficiëntie tussen vrouwen die borstvoeding en flesvoeding geven 
met de bijbehorende gezondheidsstatus en vermoeidheid. Vitamine D insufficiëntie 
bleek niet verschillend tussen de groepen die borstvoeding en flesvoeding gaven 
(57% versus 64%, p = 0.46). Er waren geen significante verschillen met betrekking 
tot gezondheidsstatus en vermoeidheid tussen vrouwen met of zonder vitamine 
D sufficiëntie die borstvoeding gaven. Bij de vrouwen die flesvoeding gaven werd 
significant slechter gescoord op de algemene gezondheidsschaal door de vitamine D 
insufficiëntie vrouwen (p = 0.035). Deze bevinding berust waarschijnlijk op toeval of 
het effect van multipele testen, omdat dit verschil niet bij de vrouwen werd gevonden 
die borstvoeding gaven. 
Concluderend kan gesteld worden dat vitamine D status bij postpartum vrouwen niet 
geassocieerd is met het geven van borstvoeding of flesvoeding, gezondheidsstatus 
en vermoeidheid.




Hoofdstuk 5 beschrijft de prevalentie van vitamine B12 deficiëntie postpartum, 
gebaseerd op totaal vitamine B12 en het metabool actieve vitamine B12 
(holotranscobalamine). Tevens werd de hypothese onderzocht dat er een verschuiving 
plaatsvindt richting holotranscobalamine in postpartum vrouwen met onvoldoende 
beschikbare totale vitamine B12. Bij 171 postpartum vrouwen werd de fractie van 
actief vitamine B12 (holotranscobalamine/totaal vitamine B12) tussen vrouwen met 
en zonder vitamine B12 deficiëntie vergeleken. Vitamine B12 deficiëntie liet een 
spontane verbetering zien van 60 – 75% binnen 48 uur postpartum, naar 6 – 10% 
bij 5 weken postpartum. De fractie van actief vitamine B12 was significant hoger 
bij vitamine B12 deficiënte vrouwen vergeleken met vrouwen die niet vitamine B12 
deficiënt waren (p < 0.0001). 
Concluderend lijkt er een verschuiving plaats te vinden in de richting van het metabool 
actieve holotranscobalamine bij vrouwen met onvoldoende beschikbare totale 
vitamine B12. Deze resultaten suggereren dat de veranderingen van postpartum 
vitamine B12 fysiologisch zijn en worden verklaard door redistributie.
Hoofdstuk 6
In hoofdstuk 6 zijn de resultaten beschreven van vergelijkend onderzoek om ijzer 
deficiënte postpartum te definiëren middels mean corpuscular volume (MCV) of 
reticulocyte hemoglobin content (CHr). In een prospectief cohort werden anemische 
vrouwen onderverdeeld in microcytair (MCV < 80 fL, n = 30) en normocytair (MCV ≥ 
80 fL, n = 85), of lage CHr (< 28 pg , n = 30) en normale CHr (≥ 28 pg, n = 75). Slechts 
36% van de anemische vrouwen was ijzerdeficiënt. Alle anemische vrouwen werden 
behandeld met ferrofumaraat met of zonder foliumzuur gedurende 4 weken. Er werd 
geen verschil gezien in stijging van hemoglobine tussen de ijzerdeficiënte en niet-
ijzerdeficiënte groepen. De vrouwen met ijzerdeficiëntie toonden een significante 
verbetering in de richting van normalisatie van de ijzerparameters MCV en CHr, 
terwijl de niet-ijzerdeficiënte vrouwen deze verhoging niet toonden.
Concluderend kan door een combinatie van hemoglobine met MCV of CHr een 
daadwerkelijke ijzerdeficiëntie bij postpartum anemische vrouwen worden 
geïdentificeerd.
Hoofdstuk 7
In dit hoofdstuk zijn de resultaten van een gerandomiseerde gecontroleerde trial 
beschreven waarin 112 postpartum anemische vrouwen werden gerandomiseerd om 




600 mg ferrofumaraat en 1 mg foliumzuur per dag te ontvangen (n = 48) of alleen 600 
mg ferrofumaraat per dag (n = 43) gedurende 4 weken. Na behandeling werden geen 
verschillen tussen beide groepen waargenomen in hemoglobine, gezondheidsstatus 
en vermoeidheid. Ongeveer 75% van alle vrouwen meldde ten minste één bijwerking 
ten gevolge van ferrofumaraat gebruik. Constipatie veroorzaakt door ferrofumaraat 
was significant geassocieerd met het staken van ferrofumaraat inname (p = 0.014).
Concluderend werd er geen toegevoegde waarde gezien van foliumzuur naast 
orale ijzer suppletie bij de behandeling van postpartum anemie ten aanzien van 
hematologische parameters, gezondheidsstatus en vermoeidheid.
Hoofdstuk 8
In hoofdstuk 8 worden de algemene discussie, conclusies en klinische implicaties 
van dit proefschrift weergegeven. De rol van vitamine D, anemie, ijzer, foliumzuur en 
vitamine B12 in associatie met gezondheidsstatus en vermoeidheid worden hierin 
uitgewerkt.
Vitamine D insufficiëntie komt voor bij ongeveer 60% van de postpartum vrouwen en 
is niet geassocieerd met de gezondheidsstatus, vermoeidheid en het geven van borst- 
of flesvoeding. Omdat de pasgeborene afhankelijk is van de vitamine D voorziening 
in de moedermelk, dient vitamine D suppletie te worden toegepast bij vrouwen die 
borstvoeding geven.
Postpartum anemie, gebaseerd op hemoglobine alleen, is niet geassocieerd met 
gezondheidsstatus en vermoeidheid. De behandeling van postpartum anemie 
bestaat veelal uit orale ijzersuppletie met of zonder foliumzuur suppletie. Echter, het 
toevoegen van foliumzuur aan deze ijzersuppletie bij de behandeling van postpartum 
anemie is niet zinvol met betrekking tot hemoglobine, gezondheidsstatus en 
vermoeidheid in ontwikkelde landen. Daarnaast blijkt slechts 36% van de vrouwen 
met postpartum anemie een ijzerdeficiëntie te hebben. Om overbehandeling en 
onnodige bijwerkingen te voorkomen, dient ijzersuppletie alleen te worden toegepast 
bij postpartum anemische vrouwen met een ijzerdeficiëntie. Door een combinatie 
van hemoglobine met MCV of CHr kunnen deze vrouwen worden geïdentificeerd
Vitamine B12 deficiëntie komt veel voor direct postpartum, maar verdwijnt spontaan 
vijf weken postpartum. Deze verandering is fysiologisch en toe te schrijven aan 
redistributie. Postpartum vrouwen zonder risicofactoren of manifestaties van een 
daadwerkelijke vitamine B12 deficiëntie, hebben geen vitamine B12 suppletie nodig.
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“Ik heb geen speciaal talent, ik ben slechts nieuwsgierig” – Albert Einstein. 
Uit nieuwsgierigheid is mijn onderzoek begonnen. Nu mijn proefschrift klaar is, is deze 
nieuwsgierigheid alleen maar toegenomen. Dit is mede dankzij het enthousiasme, 
de inspiratie en de steun van anderen. Ik wil iedereen die heeft bijgedragen aan dit 
proefschrift ontzettend bedanken. 
Allereerst wil ik alle “ijzersterke moeders” bedanken die deel hebben genomen aan 
de studies. Fijn dat jullie extra bloed wilden afstaan en dat jullie de tijd hebben 
genomen om de vragenlijsten in te vullen. Zonder jullie was het onderzoek niet 
mogelijk geweest.
Prof. dr. J. de Vries, beste Jolanda. Het is als gynaecoloog in opleiding best bijzonder 
om een Medisch Psycholoog en hoogleraar kwaliteit van leven te hebben als promotor. 
Ik vind het de perfecte match. Jij hielp me de protocollen van de klinische praktijk te 
bekritiseren door het welbevinden van onze patiënten te evalueren. Het welbevinden 
van de patiënt is tenslotte waar we het allemaal voor doen. Verder stond je altijd 
voor me klaar, als ik vastliep in de statistische analyses. Daarnaast zorgde je voor 
kritische revisies van mijn artikelen. Ik wil je heel erg bedanken voor je professionele 
begeleiding tijdens mijn promotietraject.
Dr. J.M.A. Pijnenborg, lieve Hanny. Zonder jou was dit proefschrift nooit ontstaan. 
Nadat ik als coassistent een PICO had gepresenteerd, opperde jij om samen het 
onderzoek “ijzersterke moeders” op te zetten. Na kort beraad besloot ik er voor te 
gaan. Jij hielp me vervolgens met het schrijven van het protocol, de aanvraag bij de 
medisch ethische commissie en de uitvoering in de praktijk. Je zorgde daarbij voor 
subsidie vanuit het TweeSteden ziekenhuis en vanuit de vakgroep. Later werden de 
artikelen door jou razend snel gereviseerd en je was merkbaar trots bij behaalde 
resultaten. Bedankt voor je geduld en oppeppende woorden, als het even wat minder 
ging. Ik kan niet uitdrukken hoe groot mijn bewondering voor jou is en hoe blij ik ben 
met jou als copromotor. Jouw enthousiasme, onuitputtelijke energie, positivisme, 
behulpzaamheid, nauwkeurigheid en time management zijn om jaloers op te 
worden. Je hebt me besmet met de liefde voor het onderzoek. Bedankt voor alles!
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Graag wil ik de medeauteurs dr. E.M. (Ed) van Wijk, dr. J.M. (Jacques) Verzijl, dr. C.R.B. 
(Chris) Ramakers en H.W. (Dirk) van den Brand bedanken. Beste Ed en Jacques, jullie 
zijn al vanaf het prille begin betrokken bij mijn onderzoek. Het was erg fijn om tijdens 
de brainstormsessies input te krijgen vanuit jullie oogpunten als klinisch chemicus en 
medisch apotheker. Ed, jij zorgde ervoor dat de holoTC bepalingen werden vergoed. 
Verder heb je me enorm geholpen met het vitamine B12 artikel. Jacques, dankzij jou 
zat ik nooit zonder medicatie, zodat we deze direct na randomisatie aan de vrouwen 
konden geven. Ik bedank jullie voor de bestede tijd, het enthousiasme, de kritische 
en waardevolle feedback op mijn artikelen. Beste Chris, ik stel het erg op prijs dat jij 
meteen enthousiast aan het werk ging met het CHr artikel. Voordat ik het wist, was 
het af. Beste Dirk, bedankt voor het opzetje van het vitamine D artikel. Succes met 
jouw promotie.
Beste Tom de Greve, we zijn samen begonnen met het opzetten van het “ijzersterke 
moeders” onderzoek. Doordat jij in België in opleiding ging, was het voor jou niet 
haalbaar dit onderzoek mee voort te zetten. Ik waardeer jouw geleverde inspanningen 
om het onderzoek van de grond te krijgen. Helaas kun je niet bij mijn verdediging 
aanwezig zijn, omdat je op dit moment een fellowship gynaecologische oncologie 
volgt in Zuid-Afrika. Ik wens je veel plezier en geluk met dit avontuur.
Ik wil graag de leden van de promotiecommissie bedanken. Prof. dr. R.F.P.M. 
Kruitwagen, prof. dr. A. Franx, prof. dr. J.A. Roukema, prof. dr. J. Lindemans, dr. I.A.J. 
van Rooij en dr. B.L. den Oudsten. Ik bedank u hartelijk voor de tijd en energie die u 
gespendeerd heeft om dit proefschrift te lezen en beoordelen. Tevens dank ik u voor 
het zitting nemen in mijn corona.
Maatschap gynaecologie en obstetrie van het TweeSteden ziekenhuis in Tilburg. Bij 
jullie is mijn liefde voor het vak en voor het onderzoek allemaal begonnen. Jullie zijn 
enorm fijne, inspirerende en motiverende gynaecologen. Ik wil jullie bedanken voor 
de fijne sfeer, leerzame tijd en de bijdrage en steun aan de “ijzersterke moeders”. 
Alle oud-assistenten, verloskundigen, verpleegkundigen, poli-assistentes en secreta-
resses van het TweeSteden ziekenhuis in Tilburg. Twee jaar lang heb ik genoten van 
de goede en gezellige samenwerking met jullie! De meeste inclusies heb ik te danken 
aan Lotte van Dijk, Jeanette van Leeuwen en Merel Breijer. Fijn dat jullie zo je best 
hebben gedaan voor mijn onderzoek. Beste Ton Uijt de Willigen en Jenny Bisschops, 
dankzij jullie heb ik alle geïncludeerde vrouwen terug kunnen zien. 




Gynaecologen en arts-assistenten van het Maastricht Universitair Medisch Centrum. 
Graag bedank ik jullie voor de leerzame tijd en de interesse in mijn onderzoek. 
Ik waardeer het dat mijn schrijfstage vervroegd kon worden. Daardoor is mijn 
proefschrift nu afgerond. Naast de fijne samenwerking genoot ik ook enorm van de 
gezellige activiteiten buiten het werk. De “VrijMiBo” houden we er in! We hebben echt 
een super assistentengroep!
Maatschap gynaecologie en obstetrie van het Atrium Medisch Centrum in Heerlen. Ik 
wil jullie bedanken voor alle leerzame momenten. Ik vind het fijn dat jullie geduld op 
konden brengen, wanneer ik net even teveel “ballen in de lucht” probeerde te houden. 
Ik kijk er naar uit nog veel meer van jullie te mogen leren de komende tijd! 
Collega-assistenten en oud-assistenten van het Atrium Medisch Centrum in Heerlen. 
Lieve “HeMa meisjes”, het is heerlijk om met jullie samen te (hebben) mogen werken. 
Zowel op als naast het werk is het altijd gezellig met jullie. Daarnaast motiveerden 
jullie mij om vol te houden en door te gaan, wanneer ik het even niet meer zo zag 
zitten. Heel erg bedankt dat jullie er voor me zijn!
Verloskundigen, verpleegkundigen, kraamverzorgenden, polikliniek medewerksters 
en secretaresses van het Atrium Medisch Centrum in Heerlen. Ik geniet er van om 
met jullie samen te werken. Ik waardeer jullie luisterend oor en behulpzaamheid. Het 
kopje koffie of thee tijdens de poli is heerlijk!
Lieve Arie Verwoert, jij bent voor mij een ontzettend belangrijke coach. Jij bent er op 
een fantastische manier toe in staat om mij inzicht te geven in mijzelf, waardoor ik 
sterker in het leven sta. Het is het stukje rijden dan ook altijd meer dan waard.
Lieve vrienden en vriendinnen, ondanks dat ik altijd “de nerd” uithing door eindeloze 
uren achter mijn laptop door te brengen, zijn jullie er altijd voor me geweest. Nu mijn 
promotie klaar is ga ik nog meer tijd hebben om samen met jullie van het leven te 
genieten.
Lieve Jeroen en Poy, het is altijd fijn om met jullie samen te zijn, ongeacht of dat nou 
in jullie of onze verbouwing is. Jullie ontvangen ons altijd hartelijk, vaak zelfs nog met 
een heerlijk Thais feestmaal. De oneindige uurtjes “kezen” vormen altijd een welkome 
afleiding. Dit spel is bij familie en vrienden nu ook erg geliefd. 
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Lieve Erik en Kathleen, onze Belgische vrienden. Ik prijs me gelukkig met 
Bourgondische vrienden als jullie. We vinden het heerlijk om samen van het leven 
te genieten door bijvoorbeeld een trappistje te drinken bij jullie op het terras in 
Westmalle, door samen op skivakantie te gaan en door samen te “kezen”. We hopen 
dit nog lang met jullie te kunnen doen. 
Lieve Nienke en Floris, we hebben enorm genoten van jullie bruiloft! Ik wil jullie 
bedanken voor de gezellige avondjes samen eten en “spuien”. Ook met jullie zijn we 
nog niet klaar met “kezen”.
Lieve Marion, mijn jeugdvriendin, “dikke vette bolle” (we weten allebei niet meer 
waarom we elkaar zo noemen). Het begon allemaal met “Kom jij maar naast mij 
zitten, want jou ken ik” en intussen kennen we elkaar al bijna 30 jaar. Ondanks dat we 
allebei een ander levenspad hebben gekozen, kijken we vol trots naar elkaars leven. 
Ik heb bewondering voor jouw mooie gezin. Door onze drukke levens zien we elkaar 
helaas veel minder vaak dan we eigenlijk zouden willen. Maar wanneer we samen 
zijn, is alles weer als van ouds. Jij bent altijd in mij geïnteresseerd en je bent er altijd 
voor me, dat waardeer ik enorm.
Lieve Janneke, Annette en Milou, mijn geneeskunde vriendinnen. Ik ben 
onbeschrijfelijk blij dat ik jullie heb leren kennen in het begin van onze studie in 
Nijmegen. We hebben uiteindelijk allemaal een ander specialisme gekozen en 
wonen verspreid over het land, maar dat weerhoudt ons er niet van regelmatig bij 
te kletsen in het midden van het land. Jullie bieden mij altijd een luisterend oor en 
goede adviezen, waardoor ik weer “opgeruimd” terug naar huis ga. Onze vakantie 
op Ibiza is een onvergetelijke herinnering geworden. Ik vond het enorm lastig om 
twee paranimfen te kiezen, want het liefst had ik jullie alle drie naast me gehad. 
Moeder natuur besloot voor mij toen bleek dat Milou rond mijn promotiedatum is 
uitgerekend. Ik hoop enorm dat je bij mijn promotie aanwezig kunt zijn, Milou. Na de 
komst van een prachtige dochter Emilie voor Annette, ben ik enorm benieuwd naar 
jullie zoon. 
Lieve schoonfamilie, bedankt voor jullie interesse in mijn werk, promotie en mij als 
persoon. Lieve Jan en Sonja, jullie hebben afgelopen jaren behoorlijk wat voor jullie 
kiezen gehad. Desondanks zijn jullie altijd positief, gastvrij en behulpzaam naar 
anderen. Jullie staan altijd voor ons klaar. Wat heb ik geboft met jullie! Ik kan me geen 




betere schoonouders wensen. Lieve Pieter-Jan, schoonbroer, ik bedank je voor jouw 
bereidheid mijn artikelen op correct Engels te beoordelen, ondanks jouw drukke 
leven in Schotland en Noorwegen. 
Lieve Joyce en Cheryl, wat fijn dat jullie mijn zussen zijn. Onze band is de laatste 
tijd nog sterker geworden. We hebben het niet altijd even makkelijk (gehad), maar 
gelukkig zijn we er voor elkaar. We hebben aan een half woord genoeg. Ik ben trots op 
jullie en ik hou van jullie! 
Lieve ouders, ik wil jullie bedanken voor de belangrijke dingen in het leven die jullie 
mij hebben geleerd. Lieve pap, jij hebt me bijvoorbeeld geleerd om hard te werken 
en altijd vriendelijk en behulpzaam te zijn naar anderen. Lieve mam, door jou weet 
ik dat je alles kunt bereiken in het leven, als je er maar voor de volle 100% voor gaat. 
Deze wijze lessen hebben me gemaakt tot wie ik nu ben, waardoor ik mijn doelen 
weet te bereiken.
Lieve opa Van der Woude en oma Hopmans. Ik vind het ongelooflijk fijn dat jullie 
er op deze dag bij kunnen zijn. Lieve opa, jammer dat oma dit niet meer mee heeft 
kunnen maken. Toch weet ik dat ze vandaag meekijkt en enorm trots zal zijn! Lieve 
“zoma”, ik heb enorm genoten van de logeerpartijen bij jou en opa (o.a. op de Beekse 
Hei). Je bent er altijd voor me, wat ik heel erg waardeer.
Lieve Arnoud, mijn liefie. Woorden schieten tekort om mijn dank naar jou uit te 
spreken. Ondanks dat het niet gemakkelijk is dat ik doordeweeks in een andere stad 
woon en werk, ben jij er altijd voor me. Je moet jouw leven vaak erg om die van mij 
heen plannen, maar dat doe je zonder probleem. Je staat altijd voor me klaar en 
je doet alles voor me. Jouw positieve instelling, humor en rationele kijk op zaken 
trekken mij weer in evenwicht. Op de juiste momenten dwing jij me rust te nemen 
en voor mezelf op te komen. Je biedt me altijd een luisterend oor en zoekt mee naar 
oplossingen al voordat ik daar om gevraagd heb. We genieten samen enorm van het 
leven en hebben al veel bijzondere dingen gezien en gedaan. Ik kan niet wachten om 
nog veel meer mooie momenten met jou te beleven. Ik kijk er naar uit om weer samen 
te wonen en de rest van ons leven samen door te brengen. Ik hou van je.




Daisy van der Woude werd geboren op 23 februari 1982 in Tilburg. Na het behalen van 
haar HAVO diploma in 1999 aan het Pauluslyceum in Tilburg, behaalde ze in 2000 
haar propedeuse voor HBO verpleegkunde aan de Fontys Hogeschool in Tilburg. 
Daarna volgde zij in de avonduren natuurkunde en scheikunde op VWO niveau bij 
het ROC Midden Brabant college in Tilburg, waarvoor zij in 2001 haar diploma kreeg. 
Overdag werkte zij bij de thuiszorg in Tilburg totdat zij in 2002 kon beginnen aan de 
studie geneeskunde aan het Radboud Universiteit Nijmegen. 
Tijdens haar coschap Gynaecologie en Obstetrie werkte Daisy in het TweeSteden 
ziekenhuis in Tilburg. Vanuit haar PICO presentatie werd het onderwerp voor haar 
promotieonderzoek geboren. Haar wetenschappelijke stage combineerde zij met haar 
keuze coschappen, waardoor zij 5 maanden op de afdeling Gynaecologie en Obstetrie 
in het TweeSteden ziekenhuis werkzaam was en daarnaast haar promotieonderzoek 
kon opstarten. In september 2008 behaalde zij haar artsexamen.
Van september 2008 tot en met september 2010 werkte zij als arts-assistent niet in 
opleiding op de afdeling Gynaecologie en Obstetrie van het TweeSteden ziekenhuis. 
Van september 2010 tot april 2011 had zij een aanstelling voor fulltime promovendus 
bij Tilburg University. Vanaf april 2011 is zij in opleiding tot gynaecoloog. De opleiding 
werd gestart in het Atrium Medisch Centrum in Heerlen (opleider Dr. F.J. Roumen, 
plaatsvervangend opleider Dr. P.E.A.M. Mercelina) en vanaf juli 2012 voortgezet in 
het Maastricht Universitair Medisch Centrum (opleider Prof. dr.  R.F.P.J. Kruitwagen, 
plaatsvervangend opleider Dr. G.A.J. Dunselman). In februari 2015 keerde zij terug 
voor de opleiding naar het Atrium Medisch Centrum in Heerlen (opleider Dr. P.E.A.M. 
Mercelina, plaatsvervangend opleider Dr. N.A.C. Smeets).
Daisy is sinds augustus 2007 gelukkig samen met Arnoud voor de Poorte.
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